SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------
FORM 10-K
(Mark One)
|X| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the fiscal year ended June 30, 1998
OR
|_| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from _________ to ________
Commission file number: 0-19746
ECOSCIENCE CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE 04-2912632
(State of incorporation) (I.R.S. Employer Identification No.)
10 ALVIN COURT 08816
EAST BRUNSWICK, NEW JERSEY (Zip Code)
(Address of principal executive offices)
732-432-8200
(Registrant's telephone number, including area code).
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $0.01 par value
(Title of class)
Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 of 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes _X_ No_____
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of the registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K [_].
As of October 2, 1998, there were outstanding 11,619,278 shares of Common Stock,
$0.01 par value per share. The aggregate market value of shares of Common Stock
held by non-affiliates of the registrant, based upon the last sales price for
such stock on that date as reported by NASDAQ, was approximately $8,411,000.
DOCUMENTS INCORPORATED BY REFERENCE
================================================================================
Number of Pages: 95 Exhibit Index on Page: 72
<PAGE>
PART I
================================================================================
Item 1. Business
- --------------------------------------------------------------------------------
General
EcoScience Corporation ("EcoScience") is engaged in the technical
marketing, sales, development and commercialization of products and services for
the following major markets: (i) specialty agriculture; (ii) postharvest fruits
and vegetables; and (iii) biological insect control for consumer and industrial
applications. The Company provides (i) sophisticated growing systems to
greenhouse operators, (ii) technologically advanced sorting, grading and packing
systems to produce packers, (iii) equipment, coatings and disease control
products, including natural biologicals for protecting fruits, vegetables and
ornamentals in storage and transit to market, and (iv) biological pest control
products to consumers and industry.
The Company serves the specialty agriculture and postharvest fruits and
vegetables markets through its three subsidiaries: Agro Dynamics, Inc. and Agro
Dynamics Canada Inc. (collectively, "AGRO") and EcoScience Produce Systems Corp.
("EPSC") which are hereinafter referred to collectively with EcoScience as the
"Company." EcoScience was incorporated under the laws of the State of Florida on
August 27, 1982, and was reincorporated in the State of Delaware on June 29,
1988. On November 18, 1992, EcoScience acquired all of the outstanding capital
stock of AGRO, an East Brunswick, New Jersey based company that engineers,
designs, markets and distributes advanced technologies, products, growing
systems and services for the North American intensive farming, horticulture,
nursery and produce packing industries. On May 24, 1994, the Company acquired
certain assets and liabilities of American Machinery Corporation ("AMC"), an
Orlando, Florida based business that provided postharvest coating products and
services to the fresh fruit and vegetable markets throughout the United States,
the Caribbean, Central America and South America. Concurrent with the
acquisition of certain assets and liabilities of AMC, the Company formed EPSC to
combine the AMC product line and operating unit with the Company's existing
activities in those markets. The Company sells termite control products for use
in consumer and industrial applications through a marketing collaboration with
Terminix International Company L.P. ("Terminix"). Additionally, the Company has
initiated an extensive testing, development and marketing program with Maruwa
Biochemical Co., Ltd. ("Maruwa Biochemical") for termite control products in
Japan (see "Collaborative Agreements").
The Company's primary products are (i) advanced growing systems based on
Stonewool(R), manufactured by Grodania A/S, (ii) sophisticated sorting, grading
and packing systems manufactured by Aweta, B.V., (iii) computerized
environmental and irrigation control systems manufactured by H. Hoogendoorn
Automation B.V., (iv) PacRite(R) and Indian River Gold(TM) coatings manufactured
by EPSC, (v) Bio-Save(R) PostHarvest BioProtectant line of products and (vi)
Bio-Blast(R) Biological Termiticide ("Bio-Blast") manufactured by EcoScience. In
addition, the Company distributes a broad array of specialty products used in
greenhouses and in fruit, vegetable and ornamental packing.
The Company operates from its headquarters in East Brunswick, New Jersey,
where it maintains sales, marketing and warehousing operations, and its Orlando,
Florida facility which contains the Company's major coatings and biologicals
production facility. The Company also maintains sales and/or customer service
offices in Visalia, California; Ventura, California; Littleton, Colorado; Union
Gap, Washington; and Milton, Ontario, Canada; and Mexico; and a technical
product sourcing office in the Netherlands.
2
<PAGE>
The Company's technology encompasses the development and application of
natural microbial pest control agents. The Company's technology enables it to
provide products and technical support for consumer and industrial insect
control applications, and growers and packers of specialty crops. The Company
also conducts research on the use of microbial agents to control plant diseases,
postharvest diseases on fruits and vegetables, and insect pests, as well as on
new applications for natural coatings to sustain nutrition and overall quality
in fresh fruits and vegetables.
In fiscal year ended June 30, 1998, the Company (i) expanded marketing of
its Bio-Save line of products for the control of postharvest fruit diseases in a
wide range of commercial applications, and (ii) began research on a USDA funded
Phase 2 Small Business Innovation Research ("SBIR") program on the prevention of
postharvest diseases of bananas, which will continue through fiscal year 2000.
In addition, the Company expects to conduct tests to extend the range of
performance and applicability for both its Bio-Save line of products and for its
Bio-Blast insect control product.
Merger
Effective September 30, 1998, Agro Power Development, Inc., a New York
corporation ("APD") became a wholly owned subsidiary of EcoScience pursuant to a
Merger Agreement dated April 28, 1998 and amended and restated as of July 31,
1998. Details of the merger are contained in the Company's Proxy Statement dated
August 10, 1998, which was filed with the Securities and Exchange Commission.
APD is, in terms of total acreage controlled by a single entity, the
largest producer of premium quality, greenhouse grown tomatoes in the United
States. APD develops, constructs and operates highly intensive agricultural
greenhouse projects and markets and sells the vegetable production of these
facilities, as well as fresh vegetables produced by other greenhouse growers,
under its Village Farms(R) brandname as a consumer product, primarily to retail
supermarkets and dedicated wholesale distribution companies throughout the
United States.
APD currently operates eight greenhouse facilities in the United States,
including one facility which is currently under construction and is
approximately sixty percent (60%) complete. If the construction of the new
facility is completed according to plan, APD's greenhouse facilities will
represent approximately 217 acres (9,387,180 square feet) of growing capacity
and four of these facilities, each of which has or is expected to have
approximately forty-one (41) acres of growing capacity, will be among the
largest greenhouses in North America. By producing, harvesting, packaging and
directly marketing all of its products, APD eliminates numerous intermediaries
(i.e. repackers, brokers and wholesalers) utilized by traditional field
producers of fresh vegetables. In order to develop additional sources of supply
and revenue, APD has entered into agreements to market and sell fresh vegetables
produced by two other greenhouse operations which currently comprise a total of
approximately 26 acres.
In addition to produce sales, APD generates revenues from management and
marketing fees paid to APD by the owners of greenhouse facilities operated by
APD. In certain instances, additional revenues are generated by designing and
managing the construction of these facilities for the greenhouse owner.
On the effective date of the Merger, Michael DeGiglio, Thomas Montanti and
Albert Vanzeyst, each of whom is a director and shareholder of APD, sold, and
Agro Acquisition Corporation (the Company's wholly owned acquisition subsidiary)
purchased, the entire 50% ownership interest of such individuals in Village
Farms of Morocco, S.A., a Moroccan company ("VF Morocco"), for 99,000 shares of
the Company's Common Stock.
3
<PAGE>
VF Morocco was established in 1994 by APD's directors and a group of
investors based in Morocco to export tomatoes grown in Morocco to Canada during
the winter. In 1997, VF Morocco began to export clementines from Morocco to the
United States. VF Morocco plans to export tomatoes and other fresh vegetables
and fruits from Morocco and Spain to the United States and Europe; however, the
United States had previously banned all tomato imports from Morocco due to
concerns over the Mediterranean fruit fly. The Company has learned that
recently, the United States approved the importation of the previously banned
products including tomatoes and other fresh vegetables and fruits from certain
regions of Morocco. Although the acquisition of VF Morocco is not expected to
have a material effect on APD's financial condition and operating results going
forward, APD believes that efforts made by VF Morocco and its shareholders to
promote additional business activities in Morocco and Europe could facilitate
APD's expansion plans.
Products
The Company's focus is on development and commercialization of products for
the following major markets: (i) specialty agriculture; (ii) postharvest fruits
and vegetables; and (iii) biological insect control for consumer and industrial
applications.
Specialty Agriculture
The Company, through AGRO, engineers, designs, markets and distributes
commercial products and provides services to the greenhouse, horticulture and
nursery markets in the United States, Canada and Mexico.
Commercial Products
Growing Systems. The Company is the exclusive distributor in the United
States, Canada, Mexico and the Caribbean of the Grodan(R) brand of stonewool, an
inert growing medium supplied by Grodania A/S, a Denmark based wholly owned
subsidiary of Rockwool International A/S. Stonewool is made by melting rock,
processing it to a fibrous material which can be flocculent or formed into solid
structures. It is both solid and porous, and designed to support the hydroponic
growth of high value crops and to improve plant root distribution and plant
yields through more efficient use of oxygen, water and fertilizer. Stonewool is
used worldwide for cultivation of a variety of plants in controlled growing
environments such as greenhouses. The distribution agreement expires on December
31, 2000. The sale of products under the distribution agreement with Grodania
A/S accounted for 40%, 42% and 45% of the Company's total product sales in
fiscal 1998, 1997 and 1996, respectively. The Company believes that revenues
under this distribution agreement will account for more than 10% of the
Company's consolidated product sales in fiscal 1999.
Automated Irrigation and Environmental Control Systems. The Company through
its ISYS(R) Division engineers, designs, fabricates, assembles and distributes
greenhouse irrigation and fertilization systems, computerized environmental
control systems and application products. In addition, to these products and
systems, the Company provides customers with technical support, product service,
turnkey installation, product marketing and other supplementary services. The
Company is the exclusive distributor in the United States, Canada and Mexico of
computerized environmental control systems and accessories produced by H.
Hoogendoorn Automation B.V, a Netherlands based company.
The Company also distributes various accessories and other product lines
for use in the intensive farming, horticulture and nursery industries in the
North American market on both an exclusive and non-exclusive basis.
4
<PAGE>
PostHarvest Fruits and Vegetables
The fruit and vegetable production industry requires specialized services,
equipment and products for the harvesting, processing and storage of produce.
Through AGRO and EPSC, the Company provides equipment, coatings and disease
control products to the fruit, vegetable and ornamental packing markets.
Commercial Products
Sorting, Grading and Packing. Once harvested, produce must be sorted,
graded and packaged for shipment and storage. The Company is the exclusive
distributor in the United States, Canada, Mexico and the Caribbean of
computerized color, weight and size sorting, grading and packing automated
systems produced by Aweta, B.V., a Netherlands based company, and ancillary
equipment. The sale of products under the distribution agreement with Aweta,
B.V. accounted for 21%, 26% and 20% of the Company's total product sales in
fiscal years 1998, 1997 and 1996, respectively. The Company believes that
revenues under this distribution agreement will account for more than 10% of the
Company's consolidated product sales in fiscal 1999.
Traditional Coating Products. Prior to shipping or storage, fruits and
vegetables are typically treated with a variety of processing and storage aids.
These are designed to enhance the appearance and preserve the quality of stored
produce. The Company manufactures, markets and provides a broad spectrum of
postharvest coating and cleaning products and services. Its traditional
protective coating and storage products include Indian River Gold, PacRite,
SEALBRITE(R) and DURA-FRESH(R). These products were originally acquired in May
1994 with the asset purchase of AMC. These traditional coating products are
conventional shellac and carnauba based coatings which have been used
successfully in the citrus and pome fruit markets. These traditional coating
products, together with the Company's Bio-Save coating products, maintain the
quality and extend the shelf life of produce by (i) providing a barrier to free
gas exchange, (ii) providing a barrier against abrasion, scuffing, bruising and
other injuries, (iii) providing a carrier for decay preventing agents, (iv)
providing a glossy appearance that is aesthetically appealing to consumers, (v)
reducing shrinkage caused by water loss and (vi) maintaining firmness of the
fruit or vegetable. The Company's traditional coating products contain materials
that are U.S. Food and Drug Administration ("FDA") approved additives or have
been listed by the FDA as "Generally Recognized As Safe" ("GRAS") and
accordingly, these coatings do not require FDA approval or registration.
PacRite, SEALBRITE, and Indian River Gold currently are sold by the Company in
the United States, the Caribbean, Central America and South America.
Bio-Save PostHarvest BioProtectant. The Bio-Save line of biological disease
inhibitors are sold through EPSC to the pear, apple and citrus markets.
Postharvest diseases and damage during storage and shipment can account for
losses ranging from 10% to 25% of total annual production of fruits and
vegetables, depending on the crop and climate. The Company has developed and
registered with the U.S. Environmental Protection Agency ("EPA") biological
products for sale using the naturally occurring microorganism, Pseudomonas
syringae, which can control the development of Blue Mold (Penicillium expansum),
Gray Mold (Botrytis cinerea) and Mucor Rot (Mucor pyriformis) on apples and
pears, and Blue Mold (P. italium), Green Mold (P. digitatum) and Sour Rot
(Geotrichum candidum) on citrus fruit. The Company has conducted successful
field trials over the last five years utilizing these microbial disease
inhibiting agents in Florida, California, Oregon, West Virginia, Massachusetts,
Michigan and Washington; and in Chile. The Company initiated commercial product
launch of its Bio-Save products in fiscal 1997 and plans for continued expansion
of product marketing and development in fiscal 1999. In 1997, the Company
received EPA registration for the use of Bio-
5
<PAGE>
Save on cherries and continues to investigate the application of Bio-Save to
control other postharvest diseases on fruits and vegetables, such as on
potatoes.
Biological Insect Control
In the biological insect control market, the Company, with collaborative
partners, has been focused on developing and selling cost effective
bioinsecticide alternatives to synthetic chemical insecticides for use in
specific applications, including sensitive use environments such as homes,
restaurants, schools and food processing facilities.
Commercial Products
Bio-Blast Biological Termiticide. The Company, together with its
collaborator, Terminix, has developed a natural fungal product to control
termites, the Bio-Blast Biological Termiticide (see "Collaborative
Arrangements"). This product contains a fungus selected for its ability to
infect and kill termites, which has been formulated for application utilizing
conventional equipment in a termite infested structure. The product uses
Metarhizium anisopliae, a naturally occurring insect killing fungus. The product
is a dry wettable powder, packaged and portioned for ease of storage and use;
and used as a water suspension. Through commercial trials, the Company has
demonstrated that Bio-Blast is an effective method for the control of termite
infestations. The Company has demonstrated that termites exposed to the fungus
in the product can spread the fungus by contact to nest mates that have not
directly contacted the fungal agent, thereby infecting and killing other
termites through the Horizontal Transfer(R) effect. The Company received EPA
product registration for the termiticide in October 1994, and subsequently
received approval for registration from 48 states. In fiscal 1996, the Company
made its initial sales to both Terminix and Maruwa Biochemical. In fiscal 1997,
the Company initiated the U.S. commercial launch of Bio-Blast in collaboration
with Terminix.
Sales and Distribution
Specialty Agriculture. The Company sells directly into this market through
AGRO. AGRO has a force of 23 people involved in sales, marketing and
distribution, engineering and design, and system installation and service at its
distribution and service centers in East Brunswick, New Jersey; Milton, Ontario,
Canada; and Ventura, California, and in its sales and service office in
Littleton, Colorado.
PostHarvest Fruits and Vegetables. The Company uses its AGRO and EPSC
direct sales operations to market and sell its sorting, grading and packing
equipment, and its traditional coatings and Bio-Save BioProtectants to fruit and
vegetable growers, packers and processors in the United States, the Caribbean,
Central America and South America. EPSC has a sales and technical support
services force of eight people located in its distribution and service centers
in Orlando, Florida and Visalia, California. AGRO has a force of eleven people
involved in sales and marketing, engineering and design, and system installation
and service in this market at its sales and service centers in Union Gap,
Washington; Milton, Ontario, Canada; East Brunswick, New Jersey and Littleton,
Colorado.
Biological Insect Control. In June 1992, the Company entered into a product
development and license agreement with Terminix for collaboration on the
development and marketing of termite control products in the United States and
Canada (see "Collaborative Agreements"). In fiscal 1996, the Company initiated
sales to Terminix for its Bio-Blast termiticide product and in fiscal 1997
initiated the U.S. commercial launch of the product in collaboration with
Terminix.
6
<PAGE>
International Sales. The Company expects to market products internationally
primarily through local and regional distributors and partners. The Company has
a development and distribution agreement with Maruwa Biochemical for
distribution of its initial biological insect control product and is in the
process of extending this agreement to its Bio-Blast Biological Termiticide in
Japan upon registration there (see "Collaborative Agreements").
Financial information segregated by major geographic area (United States
and Canada) is set forth in Note 9 to the Company's Consolidated Financial
Statements, incorporated herewith.
Manufacturing
The Company has established supply arrangements for the production of
fungal conidia, the active ingredient in the Bio-Blast product. Upon receipt of
the raw active ingredient, the Company processes, formulates and packages this
material using proprietary processes to produce the Bio-Blast product in its
Orlando, Florida manufacturing facility.
Traditional coating products are manufactured at the EPSC facility in
Orlando, Florida. Production of the Company's biological postharvest fruit
disease control product, Bio-Save, requires large scale fermentation and
formulation capacity. Currently, a single sub-contractor manufactures the
Bio-Save products for the Company. However, the Company believes other entities
would be capable of manufacturing these products. Although, to date, the Company
has been able to acquire a sufficient supply of the Bio-Save product for its
commercial sales; the inability of the sub-contractor to meet the Company's
needs for the Bio-Save products or a change in supplier could cause a delay in
filling orders, as well as a possible loss of sales, which would affect
operating results adversely.
Collaborative Agreements
U.S. Department of Agriculture. Lyme disease has become, in recent years, a
disease of significant public and medical concern through the U.S., particularly
in the Northeast. The disease is spread to people through the bite of several
species of ticks. The Company has signed a Material Transfer Agreement with the
United States Department of Agriculture's Agricultural Research Service ("ARS"),
whereby the Company provides formulated Metarhizium anisopliae to the ARS to
support their field trials against tick larvae. Laboratory trials conducted with
this fungus indicated good killing activity towards the tick larvae. Should
these trials be successful, the Company will consider further commercial
development of a product for the control of ticks capable of spreading Lyme
disease.
Maruwa Biochemical Co., Ltd. In June 1993, the Company entered into a
Development and Distribution Agreement with Maruwa Biochemical (the "Maruwa
Agreement") to commercialize the Company's initial biological insect control
product in Japan. In addition, the Company has shipped product to and is working
with Maruwa on commercialization of its Bio-Blast product in Japan. Under the
Maruwa Agreement and a proposed extension thereto, Maruwa Biochemical will
pursue at its own expense the registration and commercialization of the
Company's biological termite control product in Japan, including the initiation
of field trials and, if required, the commencement of toxicology studies. At
this time emphasis has shifted to the Bio-Blast product and the Company
anticipates entering into a formal agreement with Maruwa for the Bio-Blast
product.
The Terminix International Company, L.P. In June 1992, the Company entered
into a Product Development and License Agreement with Terminix (the "Terminix
Agreement") for collaboration on the development and marketing of termite
control products. Under the Terminix Agreement, Terminix provided funding to the
Company for the development of biological termite control products and received
exclusive rights to use and distribute any resulting products in the United
States and Canada.
7
<PAGE>
The Company has retained all rights elsewhere. The Company manufactures and
sells products to Terminix at an agreed markup over the Company's manufacturing
cost. The Company will share in any profit realized by Terminix over specified
levels. The Terminix Agreement extends until expiration of the last to expire of
any patents which may issue covering the Company's biological termite control
technology, subject to Terminix's right to terminate the agreement at any time.
The Company received EPA product registration for the termite control product in
October 1994, and subsequently received approval for registration from 48
states. In October 1996, the Company and Terminix initiated the U.S. commercial
launch of Bio-Blast.
Technology
The Company's technology has application in three broad areas: (i) the
development of natural microbial biological pesticides; (ii) the development of
fresh fruit and vegetable coatings; and (iii) providing assistance and advice to
customers on technical production methods for high value and specialty crops and
ornamentals, and the proper handling and packing of produce after harvest.
Microbial Pest Control
Microbial pesticide products are based on microorganisms isolated from the
environment, formulated and delivered to a target pest so that they kill the
pest, or control or inhibit its proliferation on the target. These
microorganisms are packaged alive and perform their function through
proliferation in the pest environment. Much of the formulation and delivery
technology developed for synthetic chemical pesticides is inappropriate for
microbial products which employ and preserve living organisms. EcoScience
microbial technology uses live microorganisms which either attack and kill a
target pest (e.g. Bio-Blast) or through natural growth inhibit the ability of a
target pest to proliferate (e.g. Bio-Save).
The following list describes the Company's proprietary microbial pest
control technologies including methods to (i) identify and isolate active
microbial agents, (ii) manufacture commercial quantities of those microbial
agents, (iii) formulate and package them as products with commercially
acceptable stability and shelf life and (iv) deliver them to the target pest
(see "Patents and Trade Secrets").
Identification of Active Ingredients. The Company has developed proprietary
assays for the screening and identification of microbial agents which are
effective in the prevention of certain plant diseases or which are lethal to
certain pests. The Company has been awarded a patent for the use of a microbial
agent identified through these proprietary assays and may file additional patent
applications.
Development of Manufacturing Methods. The Company has access to or has
developed a variety of proprietary methods for growing, processing and
harvesting microbial agents which it believes can be used to produce commercial
quantities of active ingredients for the Company's products.
Development of Formulation Systems. The Company has access to or has
developed proprietary processing systems to stabilize and extend the shelf life
of fungal and bacterial agents, and ensure their stability, longevity and
activity in use. These systems lead to formulations which allow living fungi and
bacteria to remain viable in dry, aqueous or oil based formulations until use.
This technology is the basis for the Bio-Save and Bio-Blast products. EcoScience
has been awarded U.S. patents which cover certain of its advances in this area.
Additionally, it serves as the basis for the contract formulation business
EcoScience is developing.
8
<PAGE>
Development of Packaging Systems. The Company believes to be commercially
successful, biopesticide products must remain viable in conventional
distribution channels and have a minimum shelf life of 18 to 24 months. The
Company has developed and patented certain proprietary packaging systems to
extend the shelf life of microbial agents during storage and transportation for
such a shelf life period.
Development of Delivery Systems. The Company has developed proprietary
delivery systems including insect infection chambers, sprays, dusts and gels,
that optimize performance of microbial agents by facilitating accurate delivery
of concentrated doses. EcoScience has been awarded U.S. patents which cover
certain of its advances in this area.
Fresh Fruit Coatings
The Company's coating technology utilizes FDA food grade and/or GRAS listed
products to improve the appearance of and maintain the quality of fruits after
harvest, and during storage and transit to market. The technology focuses on
controlling respiration (oxygen transport) and water loss of fruit. Restricting
respiration and reducing water loss improves delivery of fresher products to the
consumer. The key to the Company's approach is to design the appropriate coating
for each type of fruit, since different types of fruit respond differently to
respiration and water loss. In May 1994, the Company acquired a line of
traditional coating products from AMC, all of which utilize conventional shellac
and carnauba as their main ingredients that have been used successfully in the
citrus and pome (primarily apples and pears) fruit markets.
Technical Advice and Service
The Company, as an adjunct to its sales and service efforts, advises its
customers on improved technical growing methods and systems, and packing
techniques and systems. To successfully service its customers requires knowledge
of the customers' challenges and problems, and technical solutions available to
solve those problems. Customers frequently depend on the Company for such
service and advice.
Research and Development
The Company's technology has applicability to a variety of potential
products and product systems. These include various insect spray and chamber
products, plant and root fungal disease control systems, and preharvest and
postharvest coatings and disease control systems which are currently in varying
stages of development. As part of the Company's prior restructuring program, and
current cost control programs, certain research and product development
programs, and the funding thereof, have been suspended, curtailed or deferred.
Future development and funding of these and other select research and product
development programs will depend on a number of factors, including market
conditions, availability of financial, technical and other resources,
technological advancements, manufacturing capabilities, commercial potential of
resultant end products, governmental regulations, and other relevant matters
which may confront the Company in the future.
The Company's operating costs and expenses to date have, to a large extent,
related to the research and development of products and product systems for
future commercialization. Expenses incurred by the Company under third party
funded research and development programs totaled approximately $53,000, $7,000
and $0 in fiscal 1998, 1997 and 1996, respectively. Expenses incurred under
Company funded research and development programs totaled approximately $412,000,
$501,000 and $1,018,000 in fiscal 1998, 1997 and 1996, respectively.
9
<PAGE>
Technology Licensing
United States Department of Agriculture ("USDA"). The Company has an
agreement with the USDA granting the Company exclusive rights to the use of a
microbial strain developed at the USDA for the control of postharvest diseases
of pome fruits. This organism is the basis for one of the Bio-Save products and
is the subject of a pending U.S. patent application by the USDA. The license
agreement provides for a royalty to the USDA based on sales by the Company of
products incorporating the licensed microbial strain. The Company has also
licensed the worldwide rights to develop and commercialize additional biological
disease control organisms recently patented by the USDA. The organisms are
naturally occurring yeasts which effectively control the development of Blue
Mold (Penicillium expansum), Gray Mold (Botrytis cinerea) and Mucor Rot (Mucor
pyriformis) on apples and pears.
Competition
The Company faces substantial competition from a few large companies and
several smaller companies in the sale of certain products and growing systems to
greenhouses and nurseries in North America. The Company believes that its range
of products and services, and product quality, will allow it to compete
effectively in North America.
Competition in the fruit coatings market is also intense. Fruit coating
products are developed and marketed primarily by several large companies which
offer a full range of products. In addition, several smaller companies offer a
limited range of fruit coating products. The Company believes that it can
compete effectively in this market with its Bio-Save PostHarvest BioProtectant
and traditional coating products based on the cost effectiveness and the quality
of its coating formulations and services.
In the pesticide industry, the Company competes with large manufacturers of
synthetic chemical pesticides and established biopesticide companies. The
pesticide industry is dominated by large chemical companies located in the
United States, Japan and Europe. These companies have substantial financial and
technical resources, extensive sales and distribution capabilities, varied
product registration experience and the ability to manufacture products
efficiently. The Company believes that its commercial success in the pesticide
market will depend upon the continuing development of cost effective products
which compete with synthetic chemical pesticides on the basis of effectiveness,
safety and ecological benefit, as well as establishment of strong sales and
distribution networks for the Company's products.
The tomato and other vegetable markets in which APD competes or intends to
compete are highly competitive. In addition to other greenhouse producers, APD
must compete with U.S. producers of field grown tomatoes, which generally have
prices substantially below those of greenhouse tomatoes. In addition, due to
increased environmental compliance costs in the United States, competition from
producers in Mexico has increased. Certain of the producers of field tomatoes
may have greater resources than APD. APD's greenhouse competitors are located
primarily in the United States, Canada, Israel, Spain and Holland.
Government Regulation and Product Registration
In most countries throughout the world, governmental authorities require
registration of pesticides before sales are allowed. In the United States, the
EPA regulates pesticides under the Federal Insecticide, Fungicide and
Rodenticide Act ("FIFRA"). Pesticides are also regulated by the individual
states. Some states, such as California, Florida and New York, have their own
extensive
10
<PAGE>
registration requirements. In order to market products outside the United
States, the Company must receive regulatory approval from the authorities of
each applicable jurisdiction. In addition, the FDA administers the Federal Food,
Drug and Cosmetic Act ("FFDCA") and establishes standards for pesticide residues
in food to protect public health.
Detailed and complex procedures must be followed in order to obtain
approvals under FIFRA to commercialize a pesticide product. A registration
application must be submitted to the EPA for each product and must list each
pest for which the product will be used. Evaluation data for registration
includes, but may not be limited to, non-target organism testing, environmental
data, product analysis and residue studies, product performance, and toxicology
(hazards to human beings and domestic animals).
The EPA has established specific testing requirements for the registration
of microbial pesticides, which are set out in Subdivision M of the EPA's
Pesticide Assessment Guidelines. Chemical pesticides are currently subject to a
three tier toxicology testing procedure, and a four tier environmental
evaluation process. A microbial pesticide product which satisfactorily completes
both the toxicology Tier 1 tests and environmental evaluation is not required to
go through the increasingly difficult testing requirements of subsequent tiers.
Additional tests may be required, however, in response to any questions which
may arise during Tier 1 testing. The Company's product development cycle
typically anticipates two to three years of field evaluation and up to two years
for product registration, which can run concurrently with the last year of field
trials.
In October 1994, the Company received EPA registration for its Bio-Blast
termiticide. The Company subsequently received registration from 48 states. In
March 1995, the Company received EPA registration for Bio-Save 10 and Bio-Save
11 biofungicides in all states requested. In March 1996, the Company received
EPA registration for Bio-Save 1000, Bio-Save 100 and Bio-Save 110. These
registrations are for new formulations of the original Bio-Save 10 and 11
products. In addition, in May 1997, the Company received approval from the EPA
for a label extension for the use of Bio-Save 1000 on cherries.
Certain of the Company's activities, including the operation of its
laboratories and manufacturing facilities, and APD's operations, have been, or
may be, subject to regulation (i) under various other state and federal laws and
regulations including the Occupational Safety and Health Act, the National
Environmental Policy Act, the Clean Air Act, the Clean Water Act, the Emergency
Planning and Community Right-To-Know Act, the Food Quality Protection Act of
1996, the Resource Conservation and Recovery Act, FIFRA, the Toxic Substances
Control Act, the Comprehensive Environmental Response, Compensation and
Liability Act, and other state and federal statutes regulating environmental
quality and (ii) by state and federal agencies, including the USDA and the FDA.
From time to time, governmental authorities review the need for additional laws
and regulations for biotechnology and pesticide products that could, if adopted,
apply to the business of the Company. The Company is unable to predict whether
any such new regulations will be adopted or whether, if adopted, they will
adversely affect its business. Historically, compliance with applicable federal,
state and local provisions which have been enacted or adopted regulating the
discharge of materials into the environment by the Company's manufacturing or
laboratory operations has had an immaterial effect upon the Company's capital
expenditures, results of operations and competitive position.
Patents and Trade Secrets
The Company owns or has rights to certain proprietary information,
including patents and patent applications, which relate to its technology and
products. The Company actively seeks protection, when appropriate, for its
products and proprietary information by means of United States
11
<PAGE>
and foreign patents. In addition, the Company may rely upon confidentiality
agreements and other contractual arrangements to protect certain proprietary
information.
The Company has been issued patents and has pending patent applications
that address its core technological strengths, with emphasis on fungal and
bacterial formulation, and storage technologies. These patents and patent
applications have been principally pursued in the U.S. and in some cases
internationally. The technology described in these patents and patent
applications is useful in the development of fungal and bacterial active
ingredient microbial pesticides. The following U.S. patents have been allowed:
(i) Method and Device for the Biological Control of Cockroaches, (ii) Method and
Device for the Biological Control of Insects, (iii) Insect Contamination
Chamber, (iv) Method and Device for the Biological Control of Flying Insects,
(v) Device for Biological Control of Cockroaches, the further development and
sale of which the Company has suspended, (vi) Device Containing Fungus for
Biological Control of Insects, (vii) Maintenance and Long Term Stabilization of
Fungal Conidia Using Surfactants and (viii) Packaged Fungal Culture Stable to
Long-Term Storage.
Together, these patents describe a set of technologies applicable to the
use of fungi for the control of insect pests, and are central to the Bio-Path(R)
chamber technology which covers cockroaches, the further development and sale of
which the Company has suspended; however, this technology can be extended to any
other insect that can be controlled via a chamber system. An additional patent,
Method for Storing Fungal Cultures and Conidia, describing further fungal
formulation technology is pending.
The Company has been issued two additional U.S. Patents which relate to the
use of bacteria, chiefly as biofungicides in the treatment of plant fungal
disease: (i) Pseudomonas Syringae ATCC 55389 and Use Thereof for Inhibiting
Microbial Decay on Fruit covering a microorganism that is the active ingredient
in Bio-Save 10, 100 and 1000, and (ii) Method and Composition for Producing
Stable Bacteria and Bacterial Formulations.
Provided maintenance fees are paid, U.S. design patents have a term of 14
years from the date of issue; and U.S. utility patents that are based on
applications filed before June 8, 1995, and that have not expired as of June 8,
1995, have a term that is the longer of 20 years from the earliest effective
filing date or 17 years from issuance. In certain instances, however, the term
may be limited to the term of a related patent claiming similar technology. The
Company has an additional pending patent application relating to a method of
extending microbial shelf life. There can be no assurance that any patents will
issue from any of the Company's patent applications or that issued patents will
provide adequate protection for the Company.
In addition to its own active ingredients, the Company has acquired the
exclusive rights to the use of microbial strains developed by the USDA for the
control of postharvest diseases of pome fruits. The USDA has been granted one
patent covering this technology and has filed a patent application covering
additional postharvest disease control agents (see "Technology Licensing").
Much of the Company's technology and many of its processes are dependent
upon the knowledge, experience and skills of certain scientific and technical
personnel. To protect its rights to its proprietary information and technology,
the Company requires all employees, consultants, advisors and collaborators to
enter into confidentiality agreements which prohibit the disclosure of
confidential information to persons unaffiliated with the Company, and which
require disclosure of and assignment to the Company ideas, developments,
discoveries and inventions made by such persons. There can be no assurance that
these agreements will prevent disclosure of the Company's confidential
information or will provide meaningful protection for the Company's confidential
information. Additionally, in the
12
<PAGE>
absence of patent protection, the Company's business may be adversely affected
by competitors who develop substantially equivalent technology.
Personnel
As of October 2, 1998, the Company had 65 full time employees. A total of
two persons are employed full time in manufacturing and production; 32 in sales,
marketing and distribution; two in engineering and design; ten in system
installation and service; three in research and development; and 16 in
management and administration. As of October 2, 1998, APD had approximately 992
full time employees, including 16 in sales, marketing and distribution; two in
construction and design services, 16 in management and administration, and
approximately 958 in greenhouse operations.
None of the Company's employees is covered by a collective bargaining
agreement. The Company considers its relations with its employees to be good.
Item 2. Properties
- --------------------------------------------------------------------------------
The Company's corporate headquarters and research and development
operations, and AGRO's New Jersey operations are located in two facilities in
East Brunswick, New Jersey. These facilities consist of 23,000 and 10,000 square
foot spaces and are under leases that expire in July 1999, and which provide an
option to renew for an additional five year term. In addition, AGRO leases
10,000 square feet of space for its sales, service and warehouse center located
in Milton, Ontario, Canada under a three year lease which expires in June 2001.
AGRO also leases a 12,000 square foot facility for its sales, service and
warehouse center in Ventura, California; as well as a 5,000 square foot facility
for its sales, service and warehouse center in Union Gap, Washington, under
various lease terms.
The Company's wholly owned subsidiary, EPSC, leases approximately 24,000
square feet of space for its headquarters, production and warehouse facilities
located in Orlando, Florida, under a five year lease which expires in May 1999,
and which provides an option to renew for an additional five year term. In
addition, EPSC leases on a month to month basis approximately 4,000 square feet
of space for its sales, service and warehouse center located in Visalia,
California.
APD's principal properties consist of its greenhouse facilities in Ringgold
and Mount Carmel, Pennsylvania; Buffalo and Wheatfield, New York; Fort Davis and
Marfa, Texas; and King George, Virginia. APD has an ownership interest in the
facilities located in Buffalo, New York; Fort Davis, Texas; Mount Carmel,
Pennsylvania; and Marfa, Texas. The remaining facilities, and the land upon
which the Buffalo and Marfa facilities are located, are leased. Each of the
greenhouses operated by APD has adjacent packing and support facilities ranging
in size from approximately 11,300 square feet at the Ringgold, Pennsylvania
facility to the approximately 170,000 square foot storage and distribution
center adjacent to the Virginia greenhouse facility. Collectively, these
facilities provide an aggregate of approximately 512,778 square feet of packing
and support space to APD. In addition, APD leases approximately 850 square feet
of office space in Charlotte, North Carolina and 500 square feet of office space
in Naples, Florida.
The Company believes that its existing facilities are adequate to meet
current requirements and that suitable additional or substitute space will be
available as needed to accommodate any expansion of operations and additional
offices.
13
<PAGE>
Item 3. Legal Proceedings
- --------------------------------------------------------------------------------
The Company is not a party to any material legal proceedings. No Director,
officer, or affiliate of the Company, nor any owner beneficially or of record of
more than 5% of the Common Stock, nor any associate of any of the foregoing, is
a party to legal proceedings adverse to the Company or any of its subsidiaries,
nor does any such person have a material interest in any such proceeding.
Item 4. Submission of Matters to a Vote of Security Holders
- --------------------------------------------------------------------------------
There were no matters submitted to a vote of security holders during the
fourth quarter of the fiscal year ended June 30, 1998.
14
<PAGE>
PART II
================================================================================
Item 5. Market for the Registrant's Common Stock and Related Stockholder Matters
- --------------------------------------------------------------------------------
The Company's Common Stock trades on The Nasdaq Stock MarketSM ("NASDAQ")
under the symbol "ECSC". As of October 2, 1998, there were approximately 277
holders of record and approximately 1,823 total beneficial holders of the
Company's Common Stock. The Company effectuated a one for five reverse stock
split effective at the close of business on September 30, 1998. The reported
closing price of the Common Stock on October 2, 1998 was $3 5/8. The Company has
never declared or paid any cash dividends on its Common Stock and does not
anticipate doing so in the foreseeable future.
The table below sets forth, for the fiscal quarters indicated, the reported
high and low closing sales prices (pre-reverse stock split prices) of the Common
Stock as reported by NASDAQ based on published financial sources.
1998 High Low
------------- ---- ---
Fourth Quarter............... $ 1 13/16 $ 1
Third Quarter................ 1 15/16 1 7/32
Second Quarter............... 2 1 3/16
First Quarter................ 1 9/16 1 1/16
1997 High Low
------------- ---------- -----
Fourth Quarter............... $ 1 3/4 $ 27/32
Third Quarter................ 2 1/2 1
Second Quarter............... 1 3/8 7/8
First Quarter................ 1 5/8 1
15
<PAGE>
Item 6. Selected Financial Data
- --------------------------------------------------------------------------------
The selected financial data presented below has been derived from the
Company's audited consolidated financial statements for each year in the five
year period ended June 30, 1998. The information below should be read in
conjunction with Management's Discussion and Analysis of Financial Condition and
Results of Operations and the Consolidated Financial Statements and related
notes which appear elsewhere in this document.
<TABLE>
<CAPTION>
Years Ended June 30,
Consolidated Statements of Operations Data: ------------------------------------------------------------
(In thousands, except per share amounts) 1998 1997 1996 1995 1994
-------- -------- -------- -------- --------
<S> <C> <C> <C> <C> <C>
Product sales ..................................................... $22,317 $20,853 $14,151 $12,335 $9,246
Cost of goods sold ................................................ 17,583 15,702 10,394 10,153 7,875
-------- -------- -------- -------- --------
Gross profit ...................................................... 4,734 5,151 3,757 2,182 1,371
-------- -------- -------- -------- --------
Operating expenses:
Research and development ....................................... 465 508 1,018 4,483 8,156
Selling and marketing .......................................... 2,943 2,463 2,594 3,672 3,043
General and administrative ..................................... 2,263 2,107 2,244 2,631 3,382
Asset valuation and restructuring (reversal) charges ........... -- (377) (1,550) 6,000 5,800
-------- -------- -------- -------- --------
Total operating expenses .................................... 5,671 4,701 4,306 16,786 20,381
-------- -------- -------- -------- --------
Operating (loss) income ........................................... (937) 450 (549) (14,604) (19,010)
-------- -------- -------- -------- --------
Other income (expense):
Research, development, licensing
fees and other income ....................................... 53 7 125 155 812
Investment income .............................................. 65 105 199 590 853
Interest and other expense ..................................... (148) (177) (603) (1,235) (208)
-------- -------- -------- -------- --------
Total other (expense) income ................................ (30) (65) (279) (490) 1,457
-------- -------- -------- -------- --------
(Loss) income before extraordinary gain ........................... (967) 385 (828) (15,094) (17,553)
Extraordinary gain on early extinguishment of debt ................ -- -- 241 -- --
-------- -------- -------- -------- --------
Net (loss) income ................................................. ($967) $385 ($587) ($15,094) ($17,553)
======== ======== ======== ======== ========
(Loss) earnings per share
- -------------------------
Basic
- -----
(Loss) income before extraordinary gain ..................... ($0.09) $0.04 ($0.09) ($1.71) ($2.27)
Extraordinary gain .......................................... -- -- 0.03 -- --
-------- -------- -------- -------- --------
Net (loss) income ........................................... ($0.09) $0.04 ($0.06) ($1.71) ($2.27)
======== ======== ======== ======== ========
Weighted average common shares outstanding .................. 10,456 10,137 9,070 8,839 7,748
======== ======== ======== ======== ========
Diluted
- -------
(Loss) income before extraordinary gain ..................... ($0.09) $0.04 ($0.09) ($1.71) ($2.27)
Extraordinary gain .......................................... -- -- 0.03 -- --
-------- -------- -------- -------- --------
Net (loss) income ........................................... ($0.09) $0.04 ($0.06) ($1.71) ($2.27)
======== ======== ======== ======== ========
Aggregate diluted shares .................................... 10,456 10,313 9,070 8,839 7,748
======== ======== ======== ======== ========
</TABLE>
16
<PAGE>
Selected Financial Data: (Continued)
<TABLE>
<CAPTION>
Years Ended June 30,
Consolidated Balance Sheet Data: ------------------------------------------------------------
(In thousands) 1998 1997 1996 1995 1994
-------- -------- -------- -------- --------
<S> <C> <C> <C> <C> <C>
Unrestricted and restricted cash, cash
equivalents, short-term investments
and marketable securities ................................... $ 891 $1,775 $ 2,639 $ 7,831 $20,141
Total assets ...................................................... 9,626 8,875 10,111 18,769 33,990
Debt and capital leases ........................................... 1,104 11 2,452 8,290 7,933
Stockholders' investment .......................................... 3,136 4,014 2,473 2,492 18,110
</TABLE>
17
<PAGE>
Item 7. Management's Discussion and Analysis of Financial Condition and Results
of Operations
- --------------------------------------------------------------------------------
RESULTS OF OPERATIONS
General
EcoScience is engaged in the technical marketing, sales, development and
commercialization of products and services for the following major markets: (i)
specialty agriculture; (ii) postharvest fruits and vegetables; and (iii)
biological insect control for consumer and industrial applications. The Company
provides (i) sophisticated growing systems to greenhouse operators, (ii)
technologically advanced sorting, grading and packing systems to produce
packers, (iii) equipment, coatings and disease control products, including
natural biologicals for protecting fruits, vegetables and ornamentals in storage
and transit to market, and (iv) biological pest control products to consumers
and industry.
Specialty Agriculture
The Company engineers, designs, markets and distributes sophisticated
growing systems and services to the greenhouse and plant nursery market in the
United States, Canada and Mexico. The Company's primary products for this market
are: (i) advanced growing systems based on Stonewool(R) inert growing medium,
manufactured by Grodania A/S; (ii) computerized environmental, irrigation and
fertigation control systems manufactured by H. Hoogendoorn Automation B.V.; and
(iii) multiple greenhouse consumable products.
PostHarvest Fruits and Vegetables
The fruit and vegetable production industry requires specialized services,
equipment and products for the harvesting, processing and storage of produce.
The Company provides equipment, coatings and disease control products to the
fruit, vegetable and ornamental packing markets. The Company's primary products
for this market are: (i) technologically advanced sorting, grading and packing
systems for produce packers, manufactured by Aweta, B.V.; and (ii) equipment,
coatings and disease control products for the protection of fruits and
ornamentals in storage and transit to market including PacRite(R) and Indian
River Gold(TM) coatings manufactured by EPSC, and the BioSave(R) PostHarvest
BioProtectant line of natural biological products.
Biological Insect Control
In the biological insect control market, the Company, with collaborative
partners, has been focused on developing and selling cost effective
bio-insecticide alternatives to synthetic chemical insecticides for use in
specific applications, including sensitive use environments such as homes,
restaurants, schools and food processing facilities. The Company's primary
product for this market is Bio-Blast(R) Biological Termiticide, a unique
biological pest control product manufactured by EcoScience.
The Company sells Bio-Blast for use in consumer and industrial applications
through a marketing collaboration with Terminix International Company L.P. In
fiscal 1997, the Company initiated the U.S. commercial launch of Bio-Blast in
collaboration with Terminix. Additionally, EcoScience has initiated an extensive
testing, development and marketing program with Maruwa
18
<PAGE>
BioChemical Co., Ltd. for biological products in Japan. The Company commenced
shipments of Bio-Blast to Maruwa in fiscal 1997.
The Company's technology is used for the development and application of
natural microbial pest control agents and coatings to sustain the freshness of
fruits. The Company's technology enables it to provide technical support for
growers and packers of specialty crops. The Company conducts research on the use
of microbial agents to control plant diseases and insect pests, as well as on
new applications for natural coatings to sustain the nutritional and overall
qualities in fresh fruit. The Company expects to conduct tests to determine the
possibility of extending the range of performance and applicability for both its
Bio-Save line of products and its Bio-Blast insect control product.
The Company derives most of its revenues from the sale of: (i) growing
medium products to the North American intensive farming and horticulture
industries; (ii) sorting, grading and packing systems to the produce packing
industry; and (iii) postharvest coating products to the fresh fruit market
throughout the western hemisphere.
The Company believes inflation and changing prices have not had an material
effect on its operations to date.
Merger with Agro Power Development, Inc.
On September 30, 1998, the Company issued 9,421,487 shares of common stock
to the holders of the common stock of Agro Power Development, Inc., a privately
held corporation, pursuant to an Agreement and Plan of Merger in which APD was
merged into a newly formed, wholly owned subsidiary of the Company. The
stockholders of APD received 30,619.067 shares of the Company's common stock for
each outstanding share of common stock of APD. In addition, on September 30,
1998, the Company issued 99,000 shares of common stock to certain shareholders
of APD for their entire 50% interest in Village Farms of Morocco, S.A., a
Moroccan company, as provided for in the Agreement and Plan of Merger. After the
merger, the stockholders of APD own approximately 80% of the outstanding shares
of the Company on a fully diluted basis.
The companies combined to form an integrated environmentally focused,
consumer products driven agri-business, capitalizing on expertise in naturally
derived food technologies, intensive production and marketing of high value,
quality fresh produce, innovative bio-rational pest and disease control
technologies, and sophisticated growing and postharvest systems and products.
The Company is committed to improving the quality of its products by bridging
nature, technology and the environment utilizing the highest standards.
EcoScience believes APD will provide the combined entity greater international
presence, increased marketing capability, management depth, and the operating
level needed to accelerate revenue growth and increase shareholder value.
19
<PAGE>
1998 Compared to 1997
The Company's product sales increased $1,464,000 or 7% to $22,317,000 in
1998 from $20,853,000 in 1997 primarily due to an increase in Specialty
Agriculture sales of $2,705,000, partially offset by decreases in PostHarvest
Fruits and Vegetables product sales of $841,000 and Biological Insect Control
product sales of $400,000. The following table sets forth the Company's product
sales by market for 1998 and 1997:
Increase
(In thousands) 1998 1997 (Decrease)
------- ------- -------
Specialty Agriculture .................... $14,573 $11,868 $2,705
PostHarvest Fruits and Vegetables ........ 7,724 8,565 (841)
Biological Insect Control ................ 20 420 (400)
------- ------- -------
Consolidated .............................. $22,317 $20,853 $1,464
======= ======= =======
The Company is the exclusive distributor in the United States, Canada,
Mexico and the Caribbean of the Grodan brand of stonewool, an inert growing
medium supplied by Grodania A/S, a Denmark based company. The sale of products
under the Distribution Agreement with Grodania A/S accounted for 40% and 42% of
the Company's total product sales in 1998 and 1997, respectively. Additionally,
the Company has the exclusive right to sell Aweta B.V.'s, a Netherlands based
company, sorting, grading and packing products and equipment to the fruit,
vegetable and flower markets in the United States, Canada, Mexico and the
Caribbean. The sale of products under the Distribution Agreement with Aweta B.V.
accounted for 21% and 26% of the Company's total product sales in 1998 and 1997,
respectively. The Company believes that revenues under these distribution
agreements will each account for more than 10% of the Company's consolidated
product sales for the fiscal year ending June 30, 1999. Although there are a
limited number of sources of growing medium products, and sorting, grading and
packing equipment manufacturers in the world, the Company's management believes
that if the Company ceased to operate under its current distribution
arrangements, the Company could arrange distribution agreements with other
manufacturers or suppliers of such products and equipment on comparable terms.
Any such change, however, could cause the Company delays in filling sales
orders, as well as possible loss of sales, which would adversely affect the
Company's operating results.
In April 1998, Aweta B.V. sustained fire damage to its manufacturing
facility and certain contents therein. As a result of the fire, there has been a
delay in the shipment and installation of certain sorting, grading and packing
equipment with the primary effect being a shifting of revenue and corresponding
operating profits from the quarters ending June 30, 1998 and September 30, 1998
to the quarter ending December 31, 1998 or thereafter. The Company is attempting
to balance the effects of the temporary decrease in Aweta's production capacity
and the Company's customers' installation and production requirements. The
Company, however, cannot be assured that delayed delivery and installation of
equipment to the customer will meet the customer's requirements which could
result in the possible loss of certain customer orders and corresponding loss of
revenue and operating profit. The result of the postponement of shipments caused
by the fire has been an adverse effect on the Company's operating results for
the fourth quarter of fiscal 1998; however, in those periods where delivery is
expected to be made, there will be a favorable impact on operating results.
The Company sold products to APD in the amount of $5,012,000 or 22% of
product sales in 1998 and $2,954,000 or 14% of product sales in 1997. Management
believes that prices and fees charged to APD were consistent with those that
would be changed in arm's length translations. Had the merger not occurred,
sales to APD were expected to account for more than 10% of the Company's total
20
<PAGE>
product sales for the fiscal year ending June 30, 1999. See Item 13 - Certain
Relationships and Related Transactions.
Cost of goods sold increased $1,881,000 or 12% to $17,583,000 in 1998 from
$15,702,000 in 1997, primarily due to product sales increases and a change in
product mix.
Gross margin on product sales decreased $417,000 or 8% to $4,734,000 in
1998 from $5,151,000 in 1997, while gross margin percentage on product sales
decreased to 21% in 1998 from 25% in 1997. The decrease in gross margin was
primarily due to competitive pressures in the growing medium portion of the
Specialty Agricultural market, a reduction in equipment product sales in the
PostHarvest Fruits and Vegetables market due to the delayed shipment and
installation of equipment orders as a result of the fire at Aweta B.V., reduced
sales of the comparatively higher margin Bio-Blast product and to a lesser
extent a shift in product mix in the Specialty Agricultural market towards
certain typically lower margin product lines.
Research and development expenses decreased $43,000 or 8% to $465,000 in
1998 from $508,000 in 1997, primarily due to reductions in personnel and related
costs. The Company has and will continue to incur ongoing research and
development expenses for its Bio-Save, Bio-Blast and other select programs
during fiscal 1999.
Selling and marketing expenses increased $480,000 or 19% to $2,943,000 in
1998 from $2,463,000 in 1997, primarily due to additional personnel,
promotional, customer site and related costs to support efforts to increase
market penetration and the marketing of expanded product lines in multiple
markets, partially offset by the completion of the amortization of the value of
the contract with Grodania A/S in December 1997, the value of which resulted
from the acquisition of AGRO.
General and administrative expenses increased $156,000 or 7% to $2,263,000
in 1998 from $2,107,000 in 1997, primarily due to increases in personnel and
related costs, foreign currency losses, and certain credit risks incurred from
expansion into new markets and increased sales, partially offset by a reduction
in certain insurance costs.
In June 1997, the Company reversed $300,000 of accrued restructuring costs
no longer deemed necessary for facilities consolidation and relocation, which
relate to accrued restructuring costs originally recorded in 1995.
In August 1996, the Company and a finance company reached a lease
settlement agreement under which the Company paid $880,000 to satisfy the
remaining lease obligation of approximately $1,248,000 of principal and $17,000
of accrued interest, and returned certain leased equipment with a net book value
of $308,000 to the finance company, which resulted in a reversal of a
restructuring charge of $77,000 in 1997.
The Company charged costs and expenses totaling $109,000 and $273,000
against the restructuring accruals during 1998 and 1997, respectively.
Operating income decreased $1,387,000 to a loss of ($937,000) for 1998
compared to operating income of $450,000 for 1997. The decrease in operating
income resulted from a $970,000 increase of total operating expenses in 1998
compared to 1997, in addition to a $417,000 decrease in gross profit. The
operating loss for 1998 was ($937,000), a decrease of $1,010,000, compared to
operating income of $73,000 for 1997, when the $377,000 in restructuring
reversals are excluded. Operating expenses increased $593,000 or 12% to
$5,671,000 for 1998 compared to $5,078,000 for 1997 when the restructuring
reversals are excluded.
21
<PAGE>
Other income / (expense) decreased $35,000 or 54% to ($30,000) net expense
in 1998 compared to ($65,000) net expense in 1997. The decrease was primarily
attributable to an increase of $46,000 in research and development fee income
due primarily to the start of the Company's Phase 2 SBIR program in January 1998
and a reduction in interest and other expense of $29,000 or 16% primarily due to
the decrease in interest expense resulting from the lower average level of
long-term debt and capital lease obligations outstanding during 1998 compared to
1997, partially offset by a decrease in investment income of $40,000 resulting
from a decline in the average funds available for investment in 1998 as compared
to 1997.
The Company's net income decreased $1,352,000 or $0.13 per share basic and
diluted to a net loss of ($967,000) or ($0.09) per share basic and diluted for
1998 compared to net income of $385,000 or $0.04 per share basic and diluted for
1997. Excluding the non-recurring $377,000 reversal of restructuring charges in
1997, the net loss for 1998 was ($967,000) or ($0.09) per share basic and
diluted, a $975,000 decrease compared to the net income of $8,000 or $0.00 per
share basic and diluted for 1997.
1997 Compared to 1996
The Company's product sales increased $6,702,000 or 47% to $20,853,000 in
1997 from $14,151,000 in 1996 primarily due to increases in Specialty
Agriculture sales of $3,557,000, PostHarvest Fruits and Vegetables product sales
of $2,900,000 and Biological Insect Control product sales of $245,000. The
following table sets forth the Company's product sales by market for 1997 and
1996:
Increase
(In thousands) 1997 1996 (Decrease)
------- ------- -------
Specialty Agriculture .................. $11,868 $ 8,311 $ 3,557
PostHarvest Fruits and Vegetables ...... 8,565 5,665 2,900
Biological Insect Control .............. 420 175 245
------- ------- -------
Consolidated ............................ $20,853 $14,151 $ 6,702
======= ======= =======
The sale of products under the Distribution Agreement with Grodania A/S
accounted for 42% and 45% of the Company's total product sales in 1997 and 1996,
respectively. The sale of products under the Distribution Agreement with Aweta
B.V. accounted for 26% and 20% of the Company's total product sales in 1997 and
1996, respectively.
The Company sold products to APD in the amount of $2,954,000 or 14% of
product sales in 1997 and $573,000 or 4% of product sales in 1996. Management
believes that prices and fees charged to APD were consistent with those that
would be changed in arm's length translations. See Item 13 - Certain
Relationships and Related Transactions.
Cost of goods sold increased $5,308,000 or 51% to $15,702,000 in 1997 from
$10,394,000 in 1996, primarily due to product sales increases and a change in
product mix.
Gross margin on product sales increased $1,394,000 or 37% to $5,151,000 in
1997 from $3,757,000 in 1996, while gross margin percentage on product sales
decreased to 25% in 1997 from 27% in 1996. Gross margin percentage decrease was
primarily due to competitive pressures in the growing medium portion of the
Specialty Agricultural market and a shift in product mix towards
22
<PAGE>
typically lower margin equipment product sales in the PostHarvest Fruits and
Vegetables market, partially offset by increased sales of typically higher
margin Biologicals, Bio-Blast and Bio-Save.
Research and development expenses decreased $510,000 or 50% to $508,000 in
1997 from $1,018,000 in 1996, primarily due to reductions in personnel and
related costs and certain professional fees.
Selling and marketing expenses decreased $131,000 or 5% to $2,463,000 in
1997 from $2,594,000 in 1996, primarily due to reduced personnel and related
costs, partially offset by promotional and customer site costs.
General and administrative expenses decreased $137,000 or 6% to $2,107,000
in 1997 from $2,244,000 in 1996, primarily due to decreases in personnel and
related costs.
In June 1997, the Company reversed $300,000 of accrued restructuring costs
no longer deemed necessary for facilities consolidation and relocation, which
relate to accrued restructuring costs originally recorded in 1995.
In August 1996, the Company and a finance company reached a lease
settlement agreement under which the Company paid $880,000 to satisfy the
remaining lease obligation of approximately $1,248,000 of principal and $17,000
of accrued interest, and returned certain leased equipment with a net book value
of $308,000 to the finance company, which resulted in a reversal of a
restructuring charge of $77,000 in 1997.
In 1996, the Company reversed $1,550,000 of accrued restructuring costs
that related to a termination of a lease for its Worcester corporate
headquarters and research and development facility (see Note 8 to the
Consolidated Financial Statements).
Operating income increased $999,000 to $450,000 for 1997 compared to an
operating loss of ($549,000) for 1996. The increase in operating income resulted
from a $1,394,000 increase in gross profit, partially offset by an increase of
$395,000 in total operating expenses in 1997 compared to 1996. The operating
income for 1997 was $73,000, an increase of $2,172,000, compared to an operating
loss of ($2,099,000) for 1996, when the restructuring reversals are excluded.
Operating expenses decreased $778,000 or 13% to $5,078,000 for 1997 compared to
$5,856,000 for 1996 when the restructuring reversals are excluded.
Other income / (expense) decreased $214,000 or 77% to ($65,000) net
expenses in 1997 compared to ($279,000) net expense in 1996. The decrease was
primarily attributable to a reduction in interest and other expenses of $426,000
or 71%, primarily due to the decrease in interest expense resulting from the
lower average level of long-term debt and capital lease obligations outstanding
during 1997 compared to 1996; partially offset by (i) a decrease in investment
income of $94,000 resulting from a decline in the average funds available for
investment in 1997 compared to 1996 and (ii) a $74,000 gain on sale of property
and equipment and a $51,000 gain on settlements of accounts payable recorded in
1996.
In 1996, the Company realized an extraordinary gain on the early
extinguishment of debt of $241,000 or $0.03 per share basic and diluted with no
related income tax effect (see Note 3 to the Consolidated Financial Statements).
The Company's net income increased $972,000 or $0.10 per share basic and
diluted to net income of $385,000 or $0.04 per share basic and diluted for 1997
compared to a net loss of
23
<PAGE>
($587,000) or ($0.06) per share basic and diluted for 1996. Excluding
non-recurring amounts, net income for 1997 was $8,000 or $0.00 per share basic
and diluted, a $2,386,000 or $0.26 per share basic and diluted improvement,
compared to the net loss of ($2,378,000) or ($0.26) per share basic and diluted
for 1996. The excluded non-recurring amounts are: (i) for 1997: the $377,000
reversals of restructuring charges; and (ii) for 1996: (a) the $1,550,000
reversal of accrued restructuring costs, and (b) the $241,000 extraordinary gain
on early extinguishment of debt.
LIQUIDITY AND CAPITAL RESOURCES
The Company's operations have been funded through revenues from product
sales, public and private placements of its equity securities, bank loans and
lease financings, licensing, collaborative research and development
arrangements, and investment income.
Cash and cash equivalents were $358,000 at June 30, 1998 compared to
$1,247,000 at June 30, 1997. Unrestricted and restricted cash, cash equivalents,
and short-term investments totaled $891,000 at June 30, 1998, compared to
$1,775,000 at June 30, 1997. Cash used in operating activities totaled
$1,685,000 which consisted primarily of a net loss of $967,000 and increases of
$608,000, $386,000 and $657,000 in accounts receivable, inventory and other
current assets, respectively, partially offset by an increase in accounts
payable and accrued expenses of $640,000. Cash provided by financing activities
totaled $1,176,000 in 1998, which consisted principally of borrowings of
$1,091,000 under the Company's line of credit. Cash used for investment
activities in 1998 totaled $380,000 which consisted primarily of purchases of
property and equipment of $545,000, partially offset by a decrease in noncurrent
assets of $146,000. The Company's working capital and current ratio were
$779,000 and 1.1 to 1, respectively, at June 30, 1998 compared to $1,635,000 and
1.3 to 1, respectively, at June 30, 1997.
Debt increased by $1,093,000 to $1,104,000 at June 30, 1998 compared to
$11,000 at June 30, 1997. The increase was attributable to borrowings under the
Company's line of credit.
In 1998, the Company funded $109,000 of accrued restructuring costs that
had been recorded 1995. The balance of accrued restructuring costs, $348,000
(total current and noncurrent portions), as of June 30, 1998, is expected to be
utilized in 1999 and thereafter.
The Company expects to incur administrative, business development and
commercialization expenditures in the future as it advances the development,
manufacturing and marketing of its Bio-Blast and Bio-Save products, and other
select development programs in its bio-technology operations. In addition, the
Company expects to incur incremental costs associated with its plans to expand
product lines in the Specialty Agricultural and PostHarvest Fruits and
Vegetables markets. The Company may also use cash to acquire technology,
products or companies that support the strategy of the Company.
The Company believes its $358,000 of cash and cash equivalents and $533,000
of short-term investments as of June 30, 1998, along with revenues from product
sales, and funds available under its revolving line of credit, coupled with the
financial resources of and funds available to APD and the operating capacity of
APD will be sufficient to fund the combined entity's working capital needs,
planned capital expenditures, restructuring program initiatives and related
obligations, and to service its indebtedness through June 30, 1999. The Company
may need to raise additional funds to finance its ongoing operations after June
30, 1999, although there can be no assurances that such funds will be available
on terms favorable to the Company.
24
<PAGE>
SEASONALITY
The timing of the Company's operating revenues may vary as a result of the
seasonal nature of its businesses. In addition, operating revenues may be
affected by the timing of new product launches, acquisitions, sales orders,
sales product mix and other economic factors. Operating revenues may be
concentrated in the Company's second and third quarters as a result of the North
American growing and harvesting seasons. Although the Company believes that the
historical trend in quarterly revenues for the second and third quarters of each
year are generally higher than the first and fourth quarters; there can be no
assurance that this will occur in future periods. Accordingly, quarterly or
other interim results should not be considered indicative of results to be
expected for any other quarter or for the full fiscal year.
RISK
Although the Merger did not affect 1998 operating results, the Merger may
affect the following aspects of the Company's operations: (i) changes in the
Company's debt to equity ratio; (ii) costs associated with the transaction and
restructuring changes; (iii) market risk; and (iv) credit risk.
The Merger changed the Company's debt to equity ratio from minor to
significant, which could expose the Company to, among other things, risks
associated with interest rate fluctuations. Based on an unaudited pro forma
condensed combined balance sheet as of June 30, 1998, the debt to equity ratio
of the Company before combination was 0.4 to 1; and after combination 89.4 to 1
including minority interest in debt, and 5.8 to 1 including minority interest in
equity.
The Company and APD expect to incur charges to operations currently
estimated to be $750,000 and $500,000, respectively, primarily in the quarter in
which the Merger was consummated, to reflect non-recurring costs resulting
directly from the Merger. Such costs include investment banking, legal,
accounting, printing, and other related charges. These amounts are estimates and
are subject to change. Additional and unanticipated expenses may be incurred
relating to the integration of the businesses of the Company and APD, including
sales and marketing, and administrative functions. Although the Company and APD
expect that the elimination of duplicative expenses, as well as other
efficiencies related to the integration of their respective businesses may
offset additional expenses over time, there can be no assurance that such net
benefit will be achieved in the near term or at all.
The Company is subject to a number of risks similar to those of other
companies in similar stages of development, including dependence on key
individuals, competition from other products and companies, the necessity to
develop, register and manufacture commercially usable products, the ability to
achieve profitable operations, the impact of supply and demand on market prices
for products produced and sold by APD, the impact of crop disease and
pestilence, the impact of the perishableness of products produced and sold by
APD, weather and other events impacting crop yields and greenhouse structure
damage, the impact of customer concentrations, the need to raise additional
funds through public or private debt or equity financing, especially due to the
substantial amount of capital investment required for greenhouse operations, and
the success of the Company to achieve an effective merged entity and the result
of that entity in terms of effective operations, market acceptance and corporate
position.
Financial instruments which potentially subject the Company to
concentrations of credit risk consist of accounts receivable and other
receivables. The Company primarily invests its available funds into United
States Government securities as well as investments with high quality financial
25
<PAGE>
institutions. The Company performs ongoing evaluations of its customers'
financial condition and, generally, requires no collateral from its customers.
The Company maintains reserves and allowances for potential credit losses; which
to date, such credit losses have been insignificant and within management's
expectations. The merged entity is subject to a higher level of risk of this
nature due to the higher level of business activity and a higher level of
customer concentration.
THE MERGER AND FULFILLMENT OF NASDAQ LISTING REQUIREMENTS
The National Association of Securities Dealers, Inc., has among its
continued listing requirements three criteria, fulfillment of any one of which
qualifies an issuer for continued listing on the Nasdaq SmallCap Market. An
issuer must have (i) net tangible assets of at least $2,000,000; (ii) a market
capitalization of at least $35,000,000; or (iii) net income (for the last fiscal
year or for two of the last three fiscal years) of at least $500,000.
Results for the period ended June 30, 1998, indicate that the Company no
longer meets the net tangible assets test. In addition, the Company does not
meet the minimum net income test. As of October 2, 1998, 11,619,278 shares of
the Company's Common Stock were outstanding. The reported closing price of the
Company's Common Stock on October 2, 1998 was $3 5/8, resulting in a market
capitalization of approximately $42,120,000. It is possible that the Company may
not be able to maintain the required level of market capitalization due to
possible fluctuations in the market price for its Common Stock, which may result
in Nasdaq's delisting of the Common Stock from the Nasdaq SmallCaps Market.
YEAR 2000
The Company has completed an initial assessment of its Year 2000 status. A
plan has been developed that is expected to address the Company's exposure to
the Year 2000 issue. As a part of that plan, the Company will inventory and test
its information technology ("IT") and non-IT systems. Major customers and
vendors will be contacted in order to assess their status as to Year 2000
compliance. The Year 2000 plan is expected to be implemented and completed by
approximately the end of calendar year 1998. While some of the Company's IT and
non-IT systems will need to be upgraded or replaced, the financial impact of
making the required system changes is not expected to be material to the
Company's financial position, results of operations or cash flow.
FORWARD LOOKING STATEMENTS
This report contains forward looking statements that describe the Company's
business prospects including those that relate to the merged companies. These
statements involve risks and uncertainties including, but not limited to,
regulatory uncertainty, level of demand for the Company's products and services,
product acceptance, industry wide competitive factors, seasonality factors,
timing of completion of major equipment projects, political, economic or other
conditions, and the results of the merger in terms of effective operations,
market acceptance and corporate position. Furthermore, market trends are subject
to changes which could adversely affect future results.
Item 8. Financial Statements and Supplementary Data
- --------------------------------------------------------------------------------
The Company's consolidated financial statements and supplementary
consolidated quarterly financial data for the years ended June 30, 1998, 1997
and 1996, are set forth on pages 27 through 49.
26
<PAGE>
ECOSCIENCE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
<TABLE>
<CAPTION>
June 30,
--------------------
1998 1997
-------- --------
ASSETS
<S> <C> <C>
Current assets:
Cash and cash equivalents ...................................... $ 358 $ 1,247
Short-term investments ......................................... 533 528
Accounts receivable, less reserves of $292 and $150
at June 30, 1998 and 1997, respectively ..................... 2,396 1,788
Inventories .................................................... 2,326 1,940
Other current assets ........................................... 1,499 842
-------- --------
Total current assets ........................................ 7,112 6,345
-------- --------
Property and equipment, net ........................................ 895 562
Intangible assets, net ............................................. 1,542 1,745
Other noncurrent assets ............................................ 77 223
-------- --------
Total assets ........................................... $ 9,626 $ 8,875
======== ========
LIABILITIES AND STOCKHOLDERS' INVESTMENT
Current liabilities:
Line of credit ................................................. $ 1,091 $ --
Current maturities of long-term debt ........................... 6 10
Accounts payable ............................................... 3,223 2,641
Accrued restructuring costs .................................... 198 307
Accrued expenses and other current liabilities ................. 1,815 1,752
-------- --------
Total current liabilities ................................... 6,333 4,710
-------- --------
Noncurrent liabilities:
Long-term debt, less current maturities ........................ 7 1
Other long-term liabilities .................................... 150 150
-------- --------
Total noncurrent liabilities ................................ 157 151
-------- --------
Commitments and contingencies
Stockholders' investment:
Preferred stock, $0.01 par value, 1,000,000 shares authorized;
none issued and outstanding ................................. -- --
Common stock, $0.01 par value, 25,000,000 shares authorized;
10,488,455 and 10,401,177 shares issued and outstanding
at June 30, 1998 and 1997, respectively ..................... 105 104
Additional paid-in capital ......................................... 57,304 57,222
Accumulated deficit ................................................ (54,279) (53,312)
Unrealized gain on short-term investments .......................... 6 --
-------- --------
Total stockholders' investment .............................. 3,136 4,014
-------- --------
Total liabilities and stockholders' investment ......... $ 9,626 $ 8,875
======== ========
</TABLE>
The accompanying notes are an integral part of
these consolidated financial statements.
27
<PAGE>
ECOSCIENCE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
<TABLE>
<CAPTION>
Years Ended June 30,
--------------------------------
1998 1997 1996
-------- -------- --------
<S> <C> <C> <C>
Product sales .................................... $ 22,317 $ 20,853 $ 14,151
Cost of goods sold ............................... 17,583 15,702 10,394
-------- -------- --------
Gross profit ..................................... 4,734 5,151 3,757
-------- -------- --------
Operating expenses:
Research and development ...................... 465 508 1,018
Selling and marketing ......................... 2,943 2,463 2,594
General and administrative .................... 2,263 2,107 2,244
Asset valuation and restructuring reversal .... -- (377) (1,550)
-------- -------- --------
Total operating expenses .............. 5,671 4,701 4,306
-------- -------- --------
Operating (loss) income .......................... (937) 450 (549)
-------- -------- --------
Other income (expense):
Research, development, licensing
fees and other income ...................... 53 7 125
Investment income ............................. 65 105 199
Interest and other expense .................... (148) (177) (603)
-------- -------- --------
Total other expense ................... (30) (65) (279)
-------- -------- --------
(Loss) income before extraordinary gain .......... (967) 385 (828)
Extraordinary gain on early extinguishment of debt -- -- 241
-------- -------- --------
Net (loss) income ................................ ($ 967) $ 385 ($ 587)
======== ======== ========
(Loss) earnings per share
- -------------------------
Basic
- -----
(Loss) income before extraordinary gain .... ($ 0.09) $ 0.04 ($ 0.09)
Extraordinary gain ......................... -- -- 0.03
-------- -------- --------
Net (loss) income .......................... ($ 0.09) $ 0.04 ($ 0.06)
======== ======== ========
Weighted average common shares outstanding . 10,456 10,137 9,070
======== ======== ========
Diluted
- -------
(Loss) income before extraordinary gain .... ($ 0.09) $ 0.04 ($ 0.09)
Extraordinary gain ......................... -- -- 0.03
-------- -------- --------
Net (loss) income .......................... ($ 0.09) $ 0.04 ($ 0.06)
======== ======== ========
Aggregate diluted shares ................... 10,456 10,313 9,070
======== ======== ========
</TABLE>
The accompanying notes are an integral part
of these consolidated financial statements.
28
<PAGE>
ECOSCIENCE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' INVESTMENT
(In thousands, except share amounts)
<TABLE>
<CAPTION>
Unrealized
Common Stock (Loss) Gain
----------------------- Additional on Total
Number of $0.01 Paid-in Accumulated Short-Term Stockholders'
Shares Par Value Capital Deficit Investments Investments
---------- ---------- ---------- ---------- ---------- ----------
<S> <C> <C> <C> <C> <C> <C>
Balance at June 30, 1995 ..................... 8,840,511 $ 88 $ 55,581 ($ 53,110) ($ 67) $ 2,492
Exercise of stock options .................... 1,666 -- 1 -- -- 1
Issuance of common stock in
settlement of WBDC lease .................. 500,000 5 495 -- -- 500
Unrealized gain on
short-term investments .................... -- -- -- -- 67 67
Net loss ..................................... -- -- -- (587) -- (587)
---------- ---------- ---------- ---------- ---------- ----------
Balance at June 30, 1996 ..................... 9,342,177 93 56,077 (53,697) -- 2,473
Exercise of stock options .................... 19,000 -- 17 -- -- 17
Issuance of common stock ..................... 1,040,000 11 1,128 -- -- 1,139
Net income ................................... -- -- -- 385 -- 385
---------- ---------- ---------- ---------- ---------- ----------
Balance at June 30, 1997 ..................... 10,401,177 104 57,222 (53,312) -- 4,014
Exercise of stock options .................... 87,278 1 82 -- -- 83
Unrealized gain on
short-term investments .................... -- -- -- -- 6 6
Net loss ..................................... -- -- -- (967) -- (967)
---------- ---------- ---------- ---------- ---------- ----------
Balance at June 30, 1998 ..................... 10,488,455 $ 105 $ 57,304 ($ 54,279) $ 6 $ 3,136
========== ========== ========== ========== ========== ==========
</TABLE>
The accompanying notes are an integral part
of these consolidated financial statements.
29
<PAGE>
ECOSCIENCE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
<TABLE>
<CAPTION>
Years Ended June 30,
-------------------------------
1998 1997 1996
------- ------- -------
<S> <C> <C> <C>
Cash flows from operating activities:
Net (loss) income ........................................................................ $ (967) $ 385 ($ 587)
Adjustments to reconcile net (loss) income to net cash
(used in) provided by operating activities:
Depreciation and amortization ..................................................... 332 402 580
(Gain) loss on sale of investments ................................................ -- (2) 58
Gain on sale of property and equipment ............................................ (3) -- (74)
Gain on settlement of accounts payable ............................................ -- -- (51)
Gain on settlement of debt and other liabilities .................................. -- -- (241)
Reversal of restructuring charge ................................................. -- (377) (1,550)
Foreign exchange loss (gain) ...................................................... 73 (29) (13)
Changes in current assets and liabilities:
Accounts receivable, net .................................................. (608) (236) 409
Inventories ............................................................... (386) 61 (476)
Other current assets ...................................................... (657) (15) (245)
Accounts payable and accrued expenses ..................................... 640 267 719
Accrued restructuring costs ............................................... (109) (273) (1,174)
------- ------- -------
Net cash (used in) provided by operating activities ............................... (1,685) 183 (2,645)
------- ------- -------
Cash flows from investing activities:
Purchases of property and equipment ...................................................... (545) (90) (127)
Proceeds from sale of property and equipment ............................................. 19 -- 368
Purchases of restricted cash and short-term investments .................................. -- (503) (705)
Proceeds from sale of short-term investments ............................................. -- 677 6,159
Proceeds from release of restricted cash ................................................. -- 1,205 --
Decrease (increase) in other noncurrent assets ........................................... 146 (78) 95
------- ------- -------
Net cash (used in) provided by investing activities ............................... (380) 1,211 5,790
------- ------- -------
Cash flows from financing activities:
Proceeds from issuance of stock .......................................................... -- 1,139 --
Proceeds from exercise of stock options .................................................. 83 17 1
Proceeds from long-term debt ............................................................. 17 -- 7
Net borrowings under line of credit ...................................................... 1,091 -- --
Payments on long-term debt and capital leases ............................................ (15) (2,037) (2,900)
------- ------- -------
Net cash provided by (used in) financing activities ............................... 1,176 (881) (2,892)
------- ------- -------
(Decrease) increase in cash and cash equivalents ............................................... (889) 513 253
Cash and cash equivalents at beginning of period ............................................... 1,247 734 481
------- ------- -------
Cash and cash equivalents at end of period ..................................................... $ 358 $ 1,247 $ 734
======= ======= =======
Total unrestricted and restricted cash, cash equivalents and short-term
investments at end of period ............................................................ $ 891 $ 1,775 $ 2,639
======= ======= =======
</TABLE>
The accompanying notes are an integral part
of these consolidated financial statements.
30
<PAGE>
ECOSCIENCE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 1998
1. OPERATIONS
EcoScience Corporation ("EcoScience") and its wholly owned subsidiaries
(collectively, the "Company"), Agro Dynamics, Inc. and Agro Dynamics Canada Inc.
(collectively, "AGRO") and EcoScience Produce Systems Corp. ("EPSC") are engaged
in the technical marketing, sales, development and commercialization of products
and services for the following major markets: (i) specialty agriculture; (ii)
postharvest fruits and vegetables; and (iii) biological insect control for
consumer and industrial applications. The Company provides (i) sophisticated
growing systems to greenhouse operators, (ii) technologically advanced sorting,
grading and packing systems to produce packers, (iii) equipment, coatings and
disease control products, including natural biologicals for protecting fruits,
vegetables and ornamentals in storage and transit to market, and (iv) biological
pest control products to consumers and industry. The Company serves the
specialty agriculture and postharvest fruits and vegetables markets through its
three subsidiaries.
The Company derives most of its revenues from the sale of: (i) growing
medium products to the North American intensive farming and horticulture
industries; (ii) sorting, grading and packing systems to the produce packing
industry; and (iii) postharvest coating products to the fresh fruit market
throughout the western hemisphere.
The Company is subject to a number of risks similar to those of other
companies in similar stages of development, including dependence on key
individuals, competition from other products and companies, the necessity to
develop, register, and manufacture commercially usable products, the ability to
achieve profitable operations and the need to raise additional funds through
public or private debt or equity financing.
Effective September 30, 1998, the Company consummated a merger with Agro
Power Development, Inc. ("APD"). The Company believes APD will provide the
combined entity greater international presence, increased marketing capability,
management depth, and the operating level needed to accelerate revenue growth
and increase shareholder value.
The Company believes its $358,000 of cash and cash equivalents and $533,000
of short-term investments as of June 30, 1998, along with revenues from product
sales, and funds available under its revolving line of credit, coupled with the
financial resources of and funds available to APD and the operating capacity of
APD will be sufficient to fund the combined entity's working capital needs,
planned capital expenditures, restructuring program initiatives and related
obligations, and to service its indebtedness through June 30, 1999. The Company
may need to raise additional funds to finance its ongoing operations after June
30, 1999, although there can be no assurances that such funds will be available
on terms favorable to the Company.
31
<PAGE>
See Note 8 for a discussion of the Company's prior restructuring programs,
and Note 11 and Parts I and II regarding the Merger between the Company and Agro
Power Development, Inc. and the operations of APD.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(a) Principles of Consolidation
The consolidated financial statements include the accounts of EcoScience
and its wholly owned subsidiaries, AGRO and EPSC. All material intercompany
transactions and balances have been eliminated in consolidation.
(b) Use of Estimates in the Preparation of Financial Statements
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities, and
disclosures of contingent assets and liabilities at the date of the financial
statements, and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
(c) Cash and Cash Equivalents, and Short-Term Investments
Cash and cash equivalents, and short-term investments consist of highly
liquid investments and are stated at the lower of cost or market value. Cash and
cash equivalents consist of investments with original maturities of less than 90
days. Short-term investments have original maturities greater than 90 days and
such securities are classified as available for sale in accordance with
Statement of Financial Accounting Standards ("SFAS") No. 115, "Accounting for
Certain Investments in Debt and Equity Securities." The Company uses the
specific identification method in determining the cost basis of short-term
investments, and in computing any realized gains or losses from the sale of such
securities. Net realized gains on short-term investments were $0 and $2,000 in
fiscal years 1998 and 1997, respectively. Net realized losses on short-term
investments were $58,000 in 1996.
Cash and cash equivalents consist of cash and highly liquid money market
funds, the balance of which was $358,000 and $1,247,000 at June 30, 1998 and
1997, respectively. Short-term investments consist of United States government
obligations with an original maturity date of greater than 90 days, the balance
of which was $533,000 and $528,000 at June 30, 1998 and 1997, respectively.
Aggregate fair value of the Company's short-term investments held at June 30,
1998 amounted to $533,000, whereas cost was $527,000, therefore an unrealized
gain of $6,000 is reflected in the consolidated financial statements.
(d) Concentration of Credit Risk
Financial instruments which potentially subject the Company to
concentrations of credit risk consist of accounts receivable and other
receivables. The Company primarily invests its available funds into United
States Government securities as well as investments with high quality financial
institutions. The Company performs ongoing evaluations of its customers'
financial conditions and,
32
<PAGE>
generally, requires no collateral from its customers. The Company maintains
reserves and allowances for potential credit losses; which to date, such credit
losses have been insignificant and within management's expectations.
(e) Inventories
Inventories are stated at the lower of first-in, first-out ("FIFO")
cost or market and consist of the following:
(In thousands)
-------------------------
June 30,
-------------------------
1998 1997
------ ------
Raw materials........................... $ 74 $ 17
Finished goods.......................... 2,252 1,923
------ ------
$2,326 $1,940
====== ======
Finished goods inventories include material, labor and manufacturing
overhead.
(f) Other Current Assets
Other current assets consist of the following:
<TABLE>
<CAPTION>
(In thousands)
June 30,
-----------------------------
1998
1997
------ ------
<S> <C> <C>
Prepaid insurance ...................... $ 30 $ 35
Prepaid equipment project costs ........ 838 653
Non-trade receivables .................. 59 46
Merger costs ........................... 501 --
Other .................................. 71 108
------ ------
$1,499 $ 842
====== ======
</TABLE>
The $501,000 in merger costs, along with other merger costs incurred during
the period July 1, 1998 through the effective date of the merger and such costs
incurred by APD, will be expensed in the quarter ended September 30, 1998, see
Note 11 - Subsequent Events.
33
<PAGE>
(g) Property and Equipment
Property and equipment is summarized as follows:
(In thousands)
June 30,
-----------------------------
1998 1997
--------- -------
Laboratory equipment.................... $ 65 $ 65
Furniture, fixtures and equipment....... 1,316 926
Leasehold improvements.................. 62 62
------- -----
1,443 1,053
Less accumulated depreciation and
amortization.......................... (548) (491)
------- -------
$ 895 $ 562
======= =======
The Company provides for depreciation and amortization using the declining
balance and straight line methods by charges to operations in amounts estimated
to allocate the cost of these assets over their useful lives as follows:
Classification Estimated Useful Life
- -------------- ---------------------
Laboratory equipment.................................... 5 Years
Furniture, fixtures and equipment....................... 5-7 Years
Leasehold improvements are amortized over the term of the lease or the
useful life of the asset, whichever is shorter.
(h) Intangible Assets
Intangible assets consist primarily of goodwill and other intangible assets
resulting from acquisitions accounted for using the purchase method of
accounting. Goodwill is amortized using the straight line method over 20 years.
Other intangible assets relating to acquired businesses consist principally of
amounts attributable to distribution agreements and other deferred costs. The
amortization for distribution agreements and other deferred costs is on a
straight line basis over five years.
Goodwill, net of accumulated amortization, was $1,542,000 and $1,710,000 at
June 30, 1998 and 1997, respectively. The accumulated amortization of goodwill
and other intangible assets totaled $459,000 and $823,000 at June 30, 1998 and
1997, respectively. Amortization of goodwill and other intangible assets
included in the accompanying consolidated statements of operations was $136,000,
$204,000 and $204,000 in fiscal years 1998, 1997 and 1996, respectively. During
1998, the Company completed the amortization of the value of a distribution
agreement, the original value of which amounted to $500,000; such amount
accordingly was retired.
34
<PAGE>
(i) Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consist of the following:
(In thousands)
June 30,
----------------------
1998 1997
------ ------
Payroll related costs .......................... $ 151 $ 136
Professional fees .............................. 173 146
Accrued warranty costs ......................... 72 59
Accrued inventory purchases .................... 122 83
Customer deposits .............................. 1,209 971
Other .......................................... 88 357
------ ------
$1,815 $1,752
====== ======
(j) Revenue Recognition
Product sales revenue is recognized upon shipment or equipment
installation, as applicable. Certain equipment installation sales are covered by
a warranty provision. The resulting warranty cost estimate is accrued when the
sale is recognized. Warranty costs are charged against accrued warranty cost as
incurred, and such accrual is reviewed periodically to assure its adequacy.
Additionally, certain equipment installation sales require customer deposits.
Such deposits are recorded as a liability until the sale is recognized, then the
deposit is applied as an offset against the receivable resulting from such sale.
The Company recognizes revenue under research and development agreements in
accordance with the terms of the respective contracts which typically stipulate
as the work is performed and costs are incurred. The Company recognizes license
fees under sales and license agreements, as certain milestones are achieved and
related non-refundable license fees are received.
(k) Research and Development Expenses
The Company charges research and development expenses to operations as
incurred. Expenses incurred by EcoScience under third party funded research and
development programs totaled approximately $53,000, $7,000, and $0 in fiscal
years 1998, 1997 and 1996, respectively. Expenses incurred under Company funded
research and development programs totaled approximately $412,000, $501,000 and
$1,018,000 in fiscal years 1998, 1997 and 1996, respectively.
(l) Foreign Currency Translation
Assets and liabilities of the Company's Canadian subsidiary are translated
into U.S. dollars at year end exchange rates. Revenue and expense items are
translated at average rates prevailing during the year. Cumulative translation
adjustments have been immaterial. Transaction gains and losses are included in
the results of operations as incurred, and amounted to, on a net (loss) gain
basis, ($3,000), $29,000, and $5,000 for fiscal years 1998, 1997, and 1996,
respectively.
35
<PAGE>
(m) Earnings Per Share
During fiscal 1998, the Company adopted Statement of Financial Accounting
Standards No. 128, "Earnings per Share," which requires presentation of both
basic and diluted earnings per share in the Consolidated Statement of
Operations. Earnings per common share (basic) as calculated in accordance with
this statement does not differ from earnings per share reported in prior
periods.
A reconciliation of weighted average common shares outstanding to the
weighted average common shares assuming dilution follows:
(In thousands)
Years ended June 30,
--------------------------
1998 1997 1996
------ ------ ------
Weighted average common shares outstanding ....... 10,456 10,137 9,070
Dilutive effect of common shares issuable (1) .... -- 176 --
------ ------ ------
Weighted average common shares outstanding
assuming dilution ............................ 10,456 10,313 9,070
====== ====== ======
(1) Issuable under common stock purchase warrants and stock option plans.
Common stock purchase warrants and stock options at June 30, 1998, 1997 and
1996 to purchase 1,407,454, 928,366 and 1,294,976 shares, respectively, of
common stock were not included in the computation of earnings per common share
assuming dilution because their effect would be anti-dilutive. See Note 11 for
Subsequent Event.
(n) Fair Value of Financial Instruments
No class of financial instrument had a material difference between its
carrying value and estimated fair value based on market quotations, projected
cash flows or other estimating methods.
36
<PAGE>
(o) Supplemental Cash Flow Information
The Company made certain cash payments and consummated certain non-cash
investing and financing transactions as summarized below:
<TABLE>
<CAPTION>
(In thousands)
Years Ended June 30,
---------------------------------
1998 1997 1996
------- ------- -------
<S> <C> <C> <C>
Cash paid for:
Interest .................................................................................. $ 135 $ 196 $ 608
Income taxes .............................................................................. 5 15 18
Non-cash investing and financing activities:
Disposition of assets under capital lease ................................................. -- 308 2,936
Termination of capital lease obligation ................................................... -- (405) (3,500)
Termination of operating lease obligation and related reduction of accrued
restructuring costs ................................................................... -- -- (2,050)
Issuance of common stock in exchange for termination of operating lease obligation......... -- -- 500
Reduction of goodwill for
purchase price adjustment ............................................................. 67 -- --
Reduction of accrued expenses and other
current liabilities for purchase price adjustment ..................................... (67) -- --
</TABLE>
(p) Long Lived Assets
The Financial Accounting Standards Board has issued Statement of Financial
Accounting Standards ("SFAS") No. 121, "Accounting for the Impairment of Long
Lived Assets and for Long Lived Assets to be Disposed of " ("SFAS 121"). The
Company was required to adopt this standard as of July 1, 1996. SFAS 121
requires, among other things, that an entity review its long lived assets and
certain related intangibles for impairment whenever changes in circumstances
indicate that the carrying amount of an asset may not be fully recoverable. As a
result of a review, the Company does not believe any impairment exists in the
recoverability of its long lived assets.
(q) Stock Based Compensation
The Financial Accounting Standards Board has issued Statement of Financial
Accounting Standards No. 123, "Accounting for Stock Based Compensation" ("SFAS
123"), which encourages, but does not require an entity account for employee
stock based compensation under a fair value based method. SFAS 123 allows an
entity to continue to measure compensation cost for employee stock based
compensation plans using the intrinsic value based method of accounting
prescribed by APB Opinion No. 25, "Accounting for Stock Issued to Employees"
("APB 25"). The Company continues to account for employee stock based
compensation using the intrinsic value based method and is required to make pro
forma disclosures of net income and earnings per share as if the fair value
based method of accounting under SFAS 123 had been applied (see Note 4).
37
<PAGE>
(r) Income Taxes
The Company accounts for income taxes under the provisions of SFAS 109,
"Accounting for Income Taxes". SFAS 109 utilizes the liability method, and
deferred taxes are determined based on the estimated future tax effects of
differences between the financial statements and tax basis of assets and
liabilities at currently enacted tax laws and rates.
(s) Reclassifications
Certain amounts in the fiscal 1997 and 1996 consolidated financial
statements have been reclassified to conform to the current year presentation.
(t) New Accounting Pronouncements
In June 1997, the FASB issued SFAS 130, "Reporting Comprehensive Income,"
which is effective for fiscal years beginning after December 15, 1997. This
statement establishes standards for reporting and presenting information on
comprehensive income and its components (revenues, expenses, gains, losses and
currency translation adjustments) in the financial statements. Also in June
1997, the FASB issued SFAS 131, "Disclosures about Segments of an Enterprise and
Related Information," which is effective beginning in fiscal 1999. This
statement revises standards for public companies to report financial and
descriptive information about reportable operating segments and certain other
geographic information. The Company is evaluating methods for adoption of these
statements, if necessary, and currently does not expect these new pronouncements
to have a material impact on its consolidated financial statements.
3. DEBT AND LEASES
(a) Revolving Line of Credit
Revolving line of credit consists of the following:
(In thousands)
June 30,
----------------------------------
1998 1997
------ ------
Revolving line of credit...... $1,091 $ --
====== =======
On April 28, 1997, the Company and its lender entered into a revolving line
of credit agreement, under which the Company may borrow up to the lesser of
$3,000,000 or the sum of (i) 85% of eligible account receivables, as defined,
and (ii) eligible inventory at stratified rates from 25% to 50% up to a maximum
of the lesser of $1,200,000 or 66.67% of the amount of eligible accounts
receivable. Funds borrowed under the revolving line of credit bear interest at a
rate of prime (8.50% at June 30, 1998) plus 2.0% and are secured by all the
assets of the Company and all of the outstanding
38
<PAGE>
common stock of AGRO owned by the Company. Interest on funds borrowed under the
revolving line of credit is payable monthly in arrears and repayment of
principal was originally due on April 27, 1998, and was subject to automatic
renewal, as provided. The Company and its lender entered into a series of four
amendments to the loan documents that extended the maturity date of the
revolving line of credit to December 28, 1998. The revolving line of credit
imposes a financial covenant on the Company that requires a minimum tangible net
worth of $750,000, as defined. As of June 30, 1998, the Company had $784,000
additional borrowing availability under the revolving line of credit.
(b) Long-Term Debt
Long-term debt consists of the following:
(In thousands)
June 30,
--------------------
1998 1997
---- ----
Installment notes .............................. $ 13 $ 11
Less current maturities ........................ (6) (10)
---- ----
$ 7 $ 1
==== ====
As of June 30, 1998, the future maturities of long-term debt are as
follows:
(In thousands)
Years Ending June 30, Amount
--------------------- ------
1999..................... $ 6
2000..................... 6
2001..................... 1
In connection with the acquisition of American Machinery Corporation
("AMC") in May 1994, the Company issued a promissory note in the principal
amount of $430,000 to the shareholder of AMC. In February 1996, the Company
settled the remaining balance of the promissory note and other acquisition
related liabilities totaling $501,000 for $251,000, excluding $9,000 of related
transaction expenses, which resulted in an extraordinary gain on the early
extinguishment of debt of $241,000 or $0.03 per share, basic and diluted, with
no related income tax effect. As part of this settlement, the Company also
issued a warrant to purchase 50,000 shares of its common stock at $2.00 per
share to the shareholder of AMC.
39
<PAGE>
(c) Leases
Future minimum lease payments under non-cancelable operating leases are as
follows:
(In thousands)
Years ending June 30, Amount
- -------------------- -------
1999............................................. $ 428
2000............................................. 146
2001............................................. 107
2002............................................. 9
-------
Total minimum lease payments.......................... $ 690
=======
Rental expense included in the accompanying consolidated statements of
operations was $370,000, $392,000, and $833,000 for fiscal years 1998, 1997 and
1996, respectively. Sublease rental income was ($32,000), (33,000) and
($346,000) for fiscal years 1998, 1997 and 1996, respectively.
4. STOCKHOLDERS' INVESTMENT
(a) Private Placement
In September 1996, the Company sold 1,040,000 unregistered shares of common
stock in a private placement. Net proceeds realized from the equity offering
totaled $1,139,000 after fees and expenses totaling $161,000. In connection with
the offering, the Company also issued a warrant to purchase 156,000 shares of
its common stock at $2.00 per share to the placement agent. The Company
registered the shares of the offering and warrant under the Securities Act of
1933. The registration was declared effective in April 1997.
40
<PAGE>
(b) Common Stock Purchase Warrants
The Company has issued warrants to purchase shares of its common stock to
certain stockholders, directors and consultants of the Company. Outstanding
warrants expire through 2002. The following table summarizes warrant activity
for the three years ended June 30, 1998:
<TABLE>
<CAPTION>
Number of Price Per Weighted Average
Warrants Share Range Exercise Price
--------- -------------- ----------------
<S> <C> <C> <C>
Outstanding at June 30, 1995 ....................... 360,047 $0.38 - $11.00 $ 6.60
Granted ...................................... 250,000 1.38 - 3.00 2.15
Canceled ..................................... (151,087) 0.38 - 9.55 4.07
------- -------------- ------
Outstanding at June 30, 1996 ....................... 458,960 1.38 - 11.00 5.01
Granted ...................................... 281,554 1.00 - 3.75 2.30
Canceled ..................................... (78,960) 6.00 - 11.00 10.22
------- -------------- ------
Outstanding at June 30, 1997 ....................... 661,554 1.00 - 9.75 3.24
Granted ...................................... -- -- - -- --
Canceled ..................................... (40,000) 6.88 - 7.00 6.91
------- -------------- ------
Outstanding at June 30, 1998 ....................... 621,554 $1.00 - $ 9.75 $ 3.00
======= ============== ======
Exercisable at June 30, 1998 ....................... 621,554 $1.00 - $ 9.75 $ 3.00
======= ============== ======
</TABLE>
(c) Stock Option Plans
In May 1991, the Board of Directors approved a stock option plan (the "1991
Plan") to grant options to acquire up to 1,300,000 shares of common stock to
employees and consultants. Options granted under the 1991 Plan vest over various
periods and expire no later than 10 years from the date of grant. Options have
been granted at the fair value of the Company's common stock on the date of
grant.
In November 1996, the Board of Directors approved an amendment to the
Company's 1991 Stock Option Plan. The amendment provides for the number of
shares of the Company's common stock which may be granted under the 1991 Stock
Option Plan shall be increased from 1,300,000 to 1,800,000 shares. The Board
authorized this increase to ensure a sufficient number of option shares would be
available for future grants. The stockholders ratified this amendment at a
special stockholders' meeting in September 1998.
41
<PAGE>
Option activity for the three years ended June 30, 1998, is summarized as
follows:
<TABLE>
<CAPTION>
Number of Price Per Weighted Average
Options Share Range Exercise Price
--------- -------------- ----------------
<S> <C> <C> <C>
Outstanding at June 30, 1995.................. 461,033 $0.38 - $11.38 $ 4.48
Granted................................. 550,500 0.56 - 1.63 0.97
Exercised............................... (1,666) 0.45 0.45
Canceled................................ (173,851) 0.60 - 11.38 0.43
------- ----- ------ -----
Outstanding at June 30, 1996.................. 836,016 0.38 - 11.38 2.17
Granted................................. 340,178 0.94 - 2.50 1.21
Exercised............................... (19,000) 0.88 0.88
Canceled................................ (271,816) 0.38 - 11.38 3.99
------- ----- ------ -----
Outstanding at June 30, 1997.................. 885,378 0.56 - 7.00 1.27
Granted................................. 33,400 0.81 - 1.63 1.30
Exercised............................... (87,278) 0.88 - 1.00 .96
Canceled................................ (45,600) 0.88 - 2.13 1.06
------- ----- ------ -----
Outstanding at June 30, 1998.................. 785,900 $0.56 - $ 7.00 $1.32
======= ===== ====== =====
Exercisable at June 30, 1998................. 613,341 $0.56 - $ 7.00 $1.31
======= ===== ====== =====
</TABLE>
All stock options and warrants granted by the Company were granted at
exercise prices not less than the fair market value of the Company's common
stock on the date of grant.
The Company accounts for its common stock purchase warrants and options
plans based upon the "intrinsic value" method set forth in APB 25. Had
compensation costs for the Company's stock option plans been determined
consistent with SFAS 123, the Company's pro-forma net loss and net loss per
share for fiscal years 1998, 1997 and 1996 would have been as follows:
<TABLE>
<CAPTION>
(In thousands)
Years Ended June 30,
------------------------------
1998 1997 1996
------ ------- -------
<S> <C> <C> <C>
Net loss....................................................($1,192) ($ 106) ($ 738)
====== ======= =======
Net loss per share, basic and diluted.......................($0.11) ($ 0.01) ($ 0.08)
====== ======= =======
</TABLE>
Because SFAS 123 has not been applied to warrants and options granted prior
to July 1, 1995, the resulting pro-forma compensation cost may not be
representative of that to be expected in future periods.
Under SFAS 123, the fair value of each stock option grant is estimated on
the date of grant using the Black-Scholes option pricing model with the weighted
average assumptions in 1998, 1997, and 1996, respectively as follows: (i) risk
free interest rate of 6% for all years; (ii) expected life of approximately
eight years for all years; and (iii) expected volatility of 67%, 70%, and 70%
for 1998, 1997, and 1996, respectively. The weighted average fair value of the
options granted during 1998, 1997, and 1996 was $0.85, $0.86, and $0.69,
respectively.
42
<PAGE>
5. INCOME TAXES
As of June 30, 1998, the Company had available net operating loss
carryforwards of approximately $45,300,000 and research and development tax
credit carryforwards of approximately $900,000 to reduce future federal income
taxes, if any. These carryforwards expire through 2011 and are subject to review
and possible adjustment by the Internal Revenue Service. The Tax Reform Act of
1986 limits a Company's ability to utilize certain net operating loss and tax
credit carryforwards in the event of a cumulative change in ownership in excess
of 50%, as defined. The Company has completed numerous financings and recently a
merger with APD which has resulted in a change in ownership in excess of 50%, as
defined. Therefore, utilization of net operating loss and tax credit
carryforwards will be limited due to ownership changes.
The components of the net deferred tax amount recognized in the accompanying
consolidated balance sheets are set forth below:
(In thousands)
June 30,
----------------------------
1998 1997
------- -------
Deferred tax assets........................ $16,500 $16,000
Valuation allowance........................ (16,500) (16,000)
------- -------
$ -- $ --
======= =======
The approximate tax effect of each type of temporary difference and
carryforward before allocation of the valuation allowance is summarized as
follows:
(In thousands)
June 30,
----------------------------
1998 1997
------- -------
Net operating losses....................... $15,400 $15,000
Other temporary differences................ 200 100
Research and development credits........... 900 900
------- -------
$16,500 $16,000
======= =======
Due to the uncertainty surrounding the timing of realizing the potential
benefits of its favorable tax attributes in future income tax returns, the
Company has recorded a valuation allowance against its otherwise recognizable
deferred tax assets.
43
<PAGE>
Income tax expense (benefit) differs from the amount computed by applying
the U.S. statutory federal income tax rate for fiscal years 1998, 1997 and 1996.
A reconciliation of the provision for (benefit from) income taxes for fiscal
years 1998, 1997 and 1996 with the applicable federal income tax rate follows:
(In thousands)
Years Ended June 30,
-------------------------
1998 1997 1996
----- ----- -----
(Benefit) provision at nominal rate .............. (34.0%) 34.0% (34.0%)
Increases (reductions) in taxes resulting from:
Net operating loss carry forward ............. -- (34.0) --
Valuation allowance .......................... 34.0 -- 34.0
Foreign income taxes ......................... -- 10.8 4.6
State income taxes ........................... 0.2 0.5 0.4
----- ----- -----
Provision for (benefit from) income taxes - % .... 0.2% 11.3% 5.0%
===== ===== =====
Provision for (benefit from) income taxes - $ .... $ 2 $ 49 $ 28
===== ===== =====
For fiscal years 1998, 1997, and 1996 income tax expense has been reflected
in general and administrative expenses, due to its immateriality.
The provision for (benefit from) income taxes for fiscal years 1998, 1997
and 1996 is primarily composed of foreign and state income taxes.
6. TRANSACTIONS WITH AFFILIATES
The Company sold product to APD in the amount of $5,012,000 or 22% of
product sales in 1998, $2,954,000 or 14% of product sales in 1997 and $573,000
or 4% of product sales in 1996. An officer of the Company is also an officer of
APD. Net amount due from APD was $696,000 and $348,000 at June 30, 1998 and
1997, respectively. APD also pays a monthly fee to the Company for facilities
and other costs amounting to $42,000, $39,000, and $55,000 for 1998, 1997, and
1996, respectively. Management believes that prices and fees charged to APD were
consistent with those that would be charged in arm's length transactions. Had
the merger not occurred, sales to APD were expected to account for more than 10%
of the Company's total product sales for the fiscal year ending June 30, 1999.
See Note 11 Subsequent Events.
7. SALES, LICENSE AND DEVELOPMENT AGREEMENTS
AGRO has a distribution agreement with an unrelated company for a term of
three years ending in December 2000, with automatic one-year extensions unless
either party elects to terminate the agreement. The agreement grants AGRO the
exclusive right to sell the unrelated company's product in the United States,
Canada, Mexico, and the Caribbean. The agreement requires AGRO to maintain
minimum annual sales which, if not met, would allow the unrelated company to
modify the exclusivity of the agreement. The sale of products under this
agreement accounted for 40%, 42% and 45% of the Company's total product sales
for the fiscal years ended June 30, 1998, 1997 and
44
<PAGE>
1996, respectively. Although there are a limited number of sources of the
particular growing medium products that are sold under this distribution
agreement, the Company's management believes that other suppliers could provide
similar products on comparable terms. A change in suppliers, however, could
cause a delay in filling orders as well as a possible loss of sales, which would
affect operating results adversely.
In August 1995, AGRO entered into a distribution agreement with an
unrelated company for an initial term of three years for the fruit, vegetable
and flower markets in the United States and Canada ending in September 1999, and
in the fruit, vegetable and flower markets in the Caribbean and Mexico ending in
August 1997, which has been extended to August 1999. These agreements will be
automatically extended for each of the respective terms set forth above unless
either party elects to terminate the agreement upon ninety days prior written
notice. The Company is currently operating under such automatic extensions. The
agreement grants AGRO the exclusive right to sell the unrelated company's
sorting, grading and packing products and equipment in the United States,
Canada, Mexico and the Caribbean. The agreement requires AGRO to secure annually
certain minimum market share percentage of the market for sorting, grading and
packing machines. The sale of products under this agreement accounted for 21%,
26% and 20% of total product sales for the fiscal years ended June 30, 1998,
1997 and 1996, respectively. Although there are a limited number of sorting,
grading and packing equipment manufacturers in the world, the Company's
management believes that other suppliers could provide similar equipment on
comparable terms. A change in supplier, however, could cause a delay in filling
orders, as well as a possible loss of sales, which would affect operating
results adversely.
In September 1995, AGRO entered into a distribution agreement with an
unrelated company for a term commencing on July 1, 1995 and ending on June 30,
1997, with automatic one year extensions unless either party elects to terminate
the agreement with three months advanced notice in writing. The agreement has
been extended to June 30, 1999. The agreement grants AGRO the exclusive right to
sell the unrelated company's environmental control products and accessories in
the United States, Canada and Mexico.
In June 1992, the Company entered into a Product Development and License
Agreement with Terminix (the "Terminix Agreement") for collaboration on the
development and marketing of termite control products. Under the Terminix
Agreement, Terminix provided funding to the Company for the development of
biological termite control products and received exclusive rights to use and
distribute any resulting products in the United States and Canada. The Company
has retained all rights elsewhere. The Company managed product development,
manufactures and sells products to Terminix at an agreed markup over the
Company's manufacturing cost. The Company will also share in any profit realized
by Terminix over specified levels. The Terminix Agreement extends until
expiration of the last to expire of any patents which may issue covering the
Company's biological termite control technology, subject to Terminix's right to
terminate the agreement at any time.
In June 1993, the Company entered into a Sales and License Agreement (the
"Maruwa Agreement") with Maruwa BioChemical Co., Ltd. to license certain
biopesticide technology for control of cockroaches. Under the agreement, Maruwa
Biochemical will pursue at its own expense the registration and
commercialization of the Company's cockroach and termite control products in
Japan. At this time emphasis has shifted to the Bio-Blast product and the
Company anticipates entering into a
45
<PAGE>
formal agreement with Maruwa for the Bio-Blast product. The Company will retain
manufacturing rights and will receive royalties on sales of Bio-Blast.
8. ASSET VALUATION AND RESTRUCTURING CHARGES
The Company's consolidated statement of operations for 1995 included a
$6,000,000 or $0.68 per share, basic and diluted, charge to write down the value
of certain assets and to provide for the costs associated with the closure of
the Company's facilities located in Worcester, Northborough, and Shrewsbury,
Massachusetts, and for reductions in the Massachusetts based work force. The
Company completed a major portion of its 1995 restructuring program activities
in fiscal 1996, 1997, and 1998, and the remaining restructuring program
initiatives are expected to be completed in fiscal 1999 and thereafter.
At the close of fiscal 1995, the Company began the implementation of the
restructuring program which was designed to shift the corporate focus from
research and development to commercial operations, in an effort to reduce
operating losses and conserve cash resources. As part of the restructuring
program, the Company eliminated substantially all of its Massachusetts based
work force (33 positions), closed the Worcester facility and all remaining
functions were moved to the Northborough facility in the first quarter of fiscal
1996. During the second quarter of fiscal 1996, the Company relocated its
Massachusetts based operations including corporate headquarters to AGRO's East
Brunswick, New Jersey facility.
In May 1993, the Company entered into a 15 year capital lease agreement for
a manufacturing facility in Northborough, Massachusetts. The present value of
the minimum lease payments under this capital lease obligation was $3,525,000 at
September 29, 1995. On September 29, 1995, the Company and the lessor entered
into a lease termination agreement under which the Company paid the lessor on
October 31, 1995 approximately $195,000; released to the lessor approximately
$305,000 held in an escrow account; and agreed to make an advance lease payment
for the period October 1995 through December 1995 to the lessor in exchange for
an early termination and release from the remaining lease obligations effective
December 31, 1995. The effect of this lease termination on the consolidated
financial statements during fiscal 1996 was to reduce assets under capital
leases by $2,936,000 and capital lease obligations by $3,500,000, and to
increase accrued restructuring costs by $73,000.
On January 11, 1996, the Company and its landlord for its Worcester
corporate headquarters and research and development facility entered into a
lease termination agreement, under which the Company paid the landlord $125,000
on January 18, 1996 and issued 500,000 shares of the Company's common stock with
a market value of $500,000 on January 22, 1996, in exchange for an immediate
termination of the lease. Additionally, the Company incurred approximately
$25,000 for expenses related to the completion of the transaction. After
accounting for these settlement provisions which totaled $650,000, the Company
reversed $1,550,000 of accrued restructuring costs in the third quarter of
fiscal 1996 that related to accrued restructuring costs which were originally
recorded in fiscal 1995 ($2,000,000) and the remaining accrued restructuring
costs which were originally recorded in fiscal 1994 ($200,000).
46
<PAGE>
In August 1996, the Company and a finance company reached a lease
settlement agreement under which the Company paid $880,000 to satisfy the
remaining lease obligation of approximately $1,248,000 of principal and $17,000
of accrued interest, and return certain leased equipment with a net book value
for $308,000 to the finance company, which resulted in a reversal of a
restructuring charge of $77,000 in 1997 from accrued restructuring costs
originally recorded in fiscal 1995 and 1994.
In June 1997, the Company reversed $300,000 of accrued restructuring costs
no longer deemed necessary for facilities consolidations and relocation, which
relate to accrued restructuring costs originally recorded in 1995.
During fiscal 1998, the Company paid and charged $109,000 of restructuring
related costs of which $39,000 related to employee severance benefits, $57,000
related to other contracted liabilities, and $13,000 related to facility
consolidations. As of June 30, 1998, accrued restructuring costs of $348,000
(total current and noncurrent portions) consisted of $237,000 for facility
consolidations and lease settlements, $98,000 for employee severance benefits
and $13,000 for other contractual liabilities.
9. GEOGRAPHIC SEGMENT INFORMATION
Financial information segregated by major geographic area is summarized as
follows:
(In thousands)
Years Ended June 30,
------------------------------------
1998 1997 1996
-------- -------- --------
Product sales:
United States .................. $ 15,383 $ 15,210 $ 9,730
Canada ......................... 6,934 5,643 4,421
-------- -------- --------
Consolidated .............. $ 22,317 $ 20,853 $ 14,151
======== ======== ========
Net (loss) income:
United States .................. ($ 790) $ 309 ($ 587)
Canada ......................... (177) 76 --
-------- -------- --------
Consolidated .............. ($ 967) $ 385 ($ 587)
======== ======== ========
June 30,
----------------------
1998 1997
-------- --------
Identifiable assets:
United States .................. $ 8,998 $ 7,829
Canada ......................... 1,379 1,226
Intercompany eliminations ...... (751) (180)
-------- --------
Consolidated .............. $ 9,626 $ 8,875
======== ========
47
<PAGE>
10. QUARTERLY FINANCIAL DATA (UNAUDITED)
The following is an analysis of certain items in the consolidated
statements of operations by quarter for fiscal 1998 and 1997:
<TABLE>
<CAPTION>
Consolidated Statements of
Operations Data: (In thousands, except per share amounts)
1998
------------------------------------------------------------------
First Quarter Second Quarter Third Quarter Fourth Quarter
------------- -------------- ------------- --------------
<S> <C> <C> <C> <C>
Revenues .................................................... $ 3,993 $ 7,859 $ 6,371 $ 4,094
Cost of goods sold .......................................... 3,088 6,248 4,949 3,298
------- ------- ------- -------
Gross profit ................................................ 905 1,611 1,422 796
Research and development .................................... 100 102 105 158
Selling, general, administrative and other .................. 1,280 1,444 1,234 1,278
------- ------- ------- -------
Net (loss) income ........................................... ($ 475) $ 65 $ 83 ($ 640)
======= ======= ======= =======
Net (loss) income per share,
basic and diluted ..................................... ($ 0.05) $ 0.01 $ 0.01 ($ 0.06)
======= ======= ======= =======
<CAPTION>
1997
------------------------------------------------------------------
First Quarter Second Quarter Third Quarter Fourth Quarter
------------- -------------- ------------- --------------
<S> <C> <C> <C> <C>
Revenues .................................................... $ 4,508 $ 7,753 $ 3,633 $ 4,959
Cost of goods sold .......................................... 3,405 6,049 2,608 3,640
------- ------- ------- -------
Gross profit ................................................ 1,103 1,704 1,025 1,319
Research and development .................................... 128 153 128 99
Asset valuation and restructuring reversal .................. (77) -- -- (300)
Selling, general, administrative and other .................. 1,173 1,180 1,208 1,074
------- ------- ------- -------
Net (loss) income ........................................... ($ 121) $ 371 ($ 311) $ 446
======= ======= ======= =======
Net (loss) income per share,
basic and diluted ..................................... ($ 0.01) $ 0.04 ($ 0.03) $ 0.04
======= ======= ======= =======
</TABLE>
11. SUBSEQUENT EVENTS
(a) Merger
On September 30, 1998, the Company issued 9,421,487 shares of common stock
to the holders of the common stock of Agro Power Development, Inc., a New York
corporation, pursuant to an Agreement and Plan of Merger in which APD was merged
into Agro Acquisition Corporation, a Delaware corporation and a newly formed,
wholly owned subsidiary of the Company. The stockholders of APD received
30,619.067 shares of the Company's common stock for each
48
<PAGE>
outstanding share of common stock of APD. In addition, on September 30, 1998,
the Company issued 99,000 shares of common stock to certain shareholders of APD
for their entire 50% interest in Village Farms of Morocco, S.A., a Moroccan
company, as provided for in the Agreement and Plan of Merger. After the merger,
the stockholders of APD own approximately 80% of the outstanding shares of the
Company on a fully diluted basis.
The merger will be accounted for under the pooling of interests method and
accordingly, historical financial data in future reports will be restated to
include APD amounts. The following unaudited pro forma data summarizes the
combined results of operations of the Company and APD as though the merger had
occurred at the beginning of fiscal 1996.
<TABLE>
<CAPTION>
(In thousands, except per share amounts) Years Ended June 30,
-------------------------------------
(Unaudited pro forma) 1998 1997 1996
---------- ---------- ----------
<S> <C> <C> <C>
Net revenues ......................................... $ 45,832 $ 36,495 $ 24,668
Pro forma net (loss) income from continuing operations (2,023) 534 (363)
Net (loss) income per common share:
Basic ............................................. (0.17) 0.05 (0.03)
Diluted ........................................... (0.17) 0.05 (0.03)
</TABLE>
(b) Amendment of Certificate of Incorporation
On September 30, 1998 the Company's certificate of incorporation was
amended to effect a one for five reverse stock split of the Company's common
stock, to increase the number of authorized shares of the Company's common stock
from 25,000,000 shares to 100,000,000 shares and to increase the number of
authorized preferred stock from 1,000,000 shares to 10,000,000 shares.
49
<PAGE>
ARTHUR ANDERSEN LLP
REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS
Board of Directors and Stockholders of EcoScience Corporation:
We have audited the accompanying consolidated balance sheets of EcoScience
Corporation (a Delaware corporation) and subsidiaries as of June 30, 1998 and
1997, and the related consolidated statements of operations, stockholders'
investment and cash flows for each of the three years in the period ended June
30, 1998. These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial
statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly,
in all material respects, the financial position of EcoScience Corporation and
subsidiaries as of June 30, 1998 and 1997, and the results of their operations
and their cash flows for each of the three years in the period ended June 30,
1998, in conformity with generally accepted accounting principles.
Arthur Andersen LLP
Roseland, New Jersey
August 26, 1998 (except
with respect to the
matters discussed in
Note 11, as to which
the date is September
30, 1998)
Item 9. Changes in and Disagreements with Accountants on Accounting and
Financial Disclosures
- --------------------------------------------------------------------------------
Not applicable.
50
<PAGE>
PART III
================================================================================
Item 10. Directors and Executive Officers of the Registrant
- --------------------------------------------------------------------------------
Directors
Directors Continuing in Office Until the 1998 Annual Meeting
Thomas Montanti
Mr. Montanti, age 74, has served as a Director of the Company since
September 1998, when he was elected to serve as a Director by the Board pursuant
to certain covenants related to the Merger between the Company and APD. Mr.
Montanti, a co-founder of APD, has been Chairman of the Board and Director of
APD since its inception in 1990. Mr. Montanti co-founded Agro Dynamics, Inc. in
1984. Currently, Mr. Montanti is President of NYPCO Industries, Inc., and New
York Protective Coverings Industry, Inc., each of which is located in New York
and distributes building products and provides specialized insulation
contracting to the marine and power generating industries.
Larry M. Nouvel (1) (2) (Resigned)
Mr. Nouvel, age 54, has served as a Director of the Company since March
1993. In September 1998, Mr. Nouvel resigned as a Director of the Company
pursuant to certain covenants related to the Merger between the Company and APD.
Mr. Nouvel is currently President of Speer Products, Inc., a company that is
primarily engaged in the development, manufacturing and marketing of insecticide
products to the non-agricultural markets. From January 1986 to May 1992, he
served as President of Roussel BioCorporation, a company that manufactures and
markets insecticide products to the non-agricultural markets. Previously, Mr.
Nouvel held several senior marketing and sales positions, including Vice
President of Marketing and Sales, for Zoecon Industries, Inc., a manufacturer
and marketer of insecticide products to the professional pest control markets.
Mr. Nouvel holds a B.A. degree in Chemistry from the University of Texas at El
Paso.
Directors Continuing in Office Until the 1999 Annual Meeting
Kenneth S. Boger (3) (Resigned)
Mr. Boger, age 51, has served as a Director of the Company since July 1993.
In September 1998, Mr. Boger resigned as a Director of the Company pursuant to
certain covenants related to the Merger between the Company and APD. Mr. Boger
is currently a partner in the Boston law firm of Warner & Stackpole LLP, the
Company's general counsel, where he has practiced corporate law since 1976. Mr.
Boger holds an A.B. from Duke University, an M.B.A. from the University of
Chicago and a J.D. from Boston College Law School.
51
<PAGE>
E. Andrews Grinstead, III (2) (3) (Resigned)
Mr. Grinstead, age 52, has served as a Director of the Company since May
1991. In September 1998, Mr. Grinstead resigned as a Director of the Company
pursuant to certain covenants related to the Merger between the Company and APD.
Mr. Grinstead is currently Chairman and Chief Executive Officer of Hybridon,
Inc., a pharmaceutical company, and serves as a director of Pharmos Corporation,
Meridien Medical Technologies and BioCapital. From October 1990 to June 1991, he
acted as a consultant and financial advisor to emerging growth companies in the
medical field, particularly bio-pharmaceutical companies. From February 1984
through September 1990, he was a Managing Director and head of PaineWebber
Incorporated's Healthcare/Life Sciences Group, Managing Director of the Life
Sciences Group at Drexel Burnham Lambert Incorporated and a Vice President of
Kidder, Peabody & Co., where he developed the Life Sciences Corporate Finance
Specialty Group. Mr. Grinstead graduated from Harvard University, the University
of Virginia School of Law and Harvard Business School.
Albert Vanzeyst
Mr. Vanzeyst, age 53, has served as a Director of the Company since
September 1998, when he was elected to serve as a Director and Executive Vice
President by the Board pursuant to certain covenants related to the Merger
between the Company and APD. Mr. Vanzeyst, a co-founder of APD, has been Chief
Operating Officer and a Director of APD since its inception in 1990. In January,
1997, he also assumed the role of President of APD. Mr. Vanzeyst has 30 years of
greenhouse design, engineering and construction experience spanning several
countries, crops and climates throughout the world. Between 1984 and 1990, Mr.
Vanzeyst was President of Dace U.S.A., Inc., a subsidiary of Dace International,
Inc., an international turn-key greenhouse construction company. Prior thereto,
he participated in the development, design and construction of numerous
greenhouse operations in several countries throughout the world. Mr. Vanzeyst
holds a degree in Foreign Trade and International Commerce from Handelavond
College in the Netherlands.
Heinz K. Wehner (1) (2)
Mr. Wehner, age 67, has served as a Director of the Company since March
1993. From March 1976 to June 1992, Mr. Wehner served in several management
positions with Chemagro Corporation and Mobay Corporation, both subsidiaries of
Bayer A.G. in Germany and, most recently, Bayer Corporation, where he served as
President of the Agricultural, Animal Health and Consumer Products Divisions.
Previously, he held several management positions with Bayer Quimicas Unidas S.A.
in Peru, including Vice President of the Agricultural Chemicals and Animal
Health Division, and with Bayer de Mexico S.A., including Vice President of the
Crop Protection and Consumer Products Division. Mr. Wehner is an advisory
director for the Commerce Bank of Kansas City, N.A. in Kansas City, Missouri.
Mr. Wehner attended Escuelas Americanas in Peru where he studied business
administration.
52
<PAGE>
Directors Continuing in Office Until the 2000 Annual Meeting
Michael A. DeGiglio
Mr. DeGiglio, age 44, has served as a Director of the Company since
November 1996, when he was elected to serve as a Director by the Board. Mr.
DeGiglio joined the Company upon its acquisition of Agro Dynamics, Inc. ("AGRO
Dynamics") in November 1992, and has served as Chief Executive Officer of AGRO
Dynamics since that time. In July 1995, Mr. DeGiglio assumed the offices of
President and Chief Executive Officer of the Company. From 1984 until joining
the Company, Mr. DeGiglio was employed by AGRO Dynamics, where he served as
Chief Executive Officer. Prior to co-founding AGRO, Mr. DeGiglio was Vice
President of International Sales for NYPCO International Inc. Mr. DeGiglio
served on active duty in the United States Navy as an Officer and Jet Aviator
from July 1976 through January 1983, and the Naval Air Reserves from 1983 to
present, currently holding the rank of Captain with the United States Naval
Reserve. Throughout his Naval career, he has held various department head
positions, completed a tour as Commanding Officer of a Jet Aviation Squadron,
performed multiple tours overseas, and has completed numerous Senior Advanced
Management courses. Mr. DeGiglio also serves as Chief Executive Officer and
Director of APD. Mr. DeGiglio received a B.S. in Aeronautical Science and
Aviation Management from Embry Riddle Aeronautical University.
David J. Ryan (1) (2) (3)
Mr. Ryan, age 43, has served as a Director of the Company since 1988. Since
1983, Mr. Ryan has been a General Partner of Copley Venture Partners, an
affiliate of Copley Partners 2, L.P., a venture capital investor in EcoScience.
Mr. Ryan has also been a Managing Partner of Mission Ventures, L.P. since 1997.
Prior to his involvement in venture capital, Mr. Ryan spent five years with
Medusa Corporation, a Midwest based manufacturer of industrial and building
products, in several financial and operating capacities. Mr. Ryan also serves as
a director of Mulberry Child Care Centers and other private companies. Mr. Ryan
holds a B.S. from Northeastern University and an M.B.A. from Case Western
Reserve University.
- ----------
(1) Member of the Compensation Committee.
(2) Member of the Audit Committee.
(3) Member of the Strategic Alternatives Committee.
Meetings and Committees of the Board of Directors
The Board held nine meetings during the fiscal year ended June 30, 1998.
Each of the Directors attended at least 75% of the Board meetings and meetings
of committees of the Board of which he was a member.
The Audit Committee consists of Messrs. Ryan and Wehner. During fiscal
1998, the full Board performed the functions of the Audit Committee which
included interactions with the Company's independent accountants to review the
scope of the annual audit, to discuss the adequacy of internal
53
<PAGE>
accounting controls and procedures, and to perform general oversight with
respect to the accounting principles applied in the financial reporting of the
Company.
The Compensation Committee's functions are to recommend to the full Board
the amount, character and method of payment of compensation to all executive
officers and certain other key employees of the Company and to administer the
Company's 1991 Stock Option Plan. The Compensation Committee consists of Messrs.
Ryan and Wehner. The Compensation Committee held one meeting during fiscal 1998.
In fiscal 1995, the Company appointed Messrs. Boger, Grinstead and Ryan to
serve on a Strategic Alternatives Committee to investigate strategic
alternatives available to the Company, including mergers, acquisitions and
technology licensing opportunities. The Strategic Alternatives Committee held
two meetings during fiscal 1998.
Executive Officers
The executive officers of the Company as of October 2, 1998 are listed
below:
<TABLE>
<CAPTION>
Executive
Name Age Position Officer Since
---- --- -------- -------------
<S> <C> <C>
Michael A. DeGiglio 44 President, Chief Executive Officer and Director 1993
J. Kevin Cobb 37 Senior Vice President - Corporate Development 1998
Harold A. Joannidi 47 Treasurer, Corporate Controller and Secretary 1995
David W. Miller 47 Senior Vice President and Chief Technology Officer 1988
David Suchniak 47 Senior Vice President and Chief Financial Officer 1998
Albert Vanzeyst 53 Executive Vice President and Director 1998
</TABLE>
Mr. DeGiglio, see description of Mr. DeGiglio's positions held in the
Company and other experience under his description as a Director.
Mr. Cobb joined the Company in September 1998, as Senior Vice
President-Corporate Development pursuant to certain covenants related to the
Merger between the Company and APD. Prior to joining the Company, Mr. Cobb
served as Senior Vice President and Chief Financial Officer of APD from January
1995 until July 1998, when he was appointed Senior Vice President - Corporate
Development of APD. Mr. Cobb came to APD after five years experience with
Cogentrix Energy, Inc. of Charlotte, North Carolina. While at Cogentrix, he
served as Treasurer and Director of Project Finance. From 1988 to 1990, he
served as Vice President of Finance of The Lexington Group, Inc., a real estate
investment and management firm. Prior thereto, Mr. Cobb was employed as a
Certified Public Accountant with Arthur Andersen, LLP. Mr. Cobb holds a B.S.
degree in accounting from the University of North Carolina - Charlotte.
Mr. Joannidi joined the Company in 1995 as Corporate Controller. In March
1996, Mr. Joannidi became Treasurer and Secretary of the Company. In 1992 and
from 1994 until joining the Company, Mr.
54
<PAGE>
Joannidi also served as a financial and systems consultant to the Company. Prior
to joining and in addition to being a consultant to the Company in 1992, Mr.
Joannidi operated a manufacturing company from 1992 to 1994, served as a
financial and systems consultant to various companies from 1988 to 1992, and
held financial management positions at Tel Plus International, Inc./Siemens AG,
Johnson Matthey Jewelry Corporation and Refinemet International Company from
1980 to 1988. Mr. Joannidi attained Certified Public Accountant designation
while employed at the public accounting firm of Coopers & Lybrand LLP. He
attended Tufts University and Northeastern University, receiving a B.S. degree
in Accounting and Economics from Northeastern University.
Dr. Miller joined the Company in May 1988 and serves as Senior Vice
President and Chief Technology Officer. Dr. Miller's current responsibilities
include technology development and management, intellectual property oversight
and product development Dr. Miller received a B.S. in Biochemistry from the
University of California, Davis, and a Ph.D. in Biochemistry and Molecular
Biology from Harvard University, where he studied the molecular biology of
insects. Dr. Miller also was a National Institutes of Health post-doctoral
Fellow studying insect viruses at the University of Idaho. Prior to joining the
Company, Dr. Miller was employed from 1983 to 1988 as Staff Scientist and
Project Leader at Genetics Institute, Inc., in Cambridge, Massachusetts.
Throughout his professional career, Dr. Miller has focused on the development
and commercialization of microbial pesticides with involvement from the
discovery stage to product sales.
Mr. Suchniak joined the Company in September 1998, as Senior Vice President
and Chief Financial Officer pursuant to certain covenants related to the Merger
between the Company and APD. Prior to joining the Company, Mr. Suchniak served
as Senior Vice President and Chief Financial Officer of APD since July 1998.
Prior to joining APD, Mr. Suchniak served as Senior Vice President and CFO with
AMC Corporation from 1995 to 1998, and Vice President/CFO with Hanover Foods
Corporation from 1992 to 1995. Mr. Suchniak is a Certified Public Accountant.
Mr.Vanzeyst, see description of Mr. Vanzeyst's positions held in the
Company and other experience under his description as a Director.
55
<PAGE>
Item 11. Executive Compensation
- --------------------------------------------------------------------------------
EXECUTIVE COMPENSATION
The following table provides certain summary information regarding
compensation paid by the Company during the fiscal years ended June 30, 1998,
1997 and 1996 to the Company's Chief Executive Officer and to each of the other
executive officers of the Company, whose annual compensation and bonus for the
fiscal year ended June 30, 1998 exceeded $100,000 (together with the Chief
Executive Officer, the "Named Executive Officers").
SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
Long Term
Compensation Awards
--------------------------------
Name and Annual Compensation Restricted Number of Shares
Principal Position -------------------------------------- Stock Underlying
------------------ Year Salary Bonus Awards Stock Options
-------------------------------------- ------ -------------
<S> <C> <C> <C> <C> <C>
Michael A. DeGiglio (1) 1998 $150,000 $ 25,000 -- --
President and Chief 1997 140,000 25,000 -- 100,000
Executive Officer 1996 123,391 25,000 -- 200,000
Harold A. Joannidi 1998 102,000 8,000 -- --
Treasurer and Secretary 1997 93,500 -- -- 50,000
1996 72,000 -- -- 35,000
David W. Miller 1998 114,500 3,500 -- --
Senior Vice President and Chief 1997 106,167 -- -- 55,000
Technology Officer 1996 108,250 -- -- 50,000
</TABLE>
(1) Mr. DeGiglio joined the Company in November 1992 as the President of Agro
Dynamics, Inc. and was appointed President and Chief Executive Officer of
the Company in July 1995.
Compensation of Directors
Each Director who is not an employee of the Company receives an annual
retainer of $5,000 for Board service, plus $750 for each Board meeting attended,
$375 for each telephonic Board meeting which lasts more than one hour and $500
for each Committee meeting attended, plus expenses. Those Directors who are
employees of the Company do not receive any compensation for their services as
Directors.
Each non-employee Director when first elected or appointed to the Board
receives a warrant to purchase 20,000 shares of Common Stock at an exercise
price equal to the fair market value on the grant date. These warrants vest at
the rate of 20 percent on the grant date and on the first anniversary of the
grant date and 30 percent on the second and third anniversaries of the grant
date. Warrants granted to Directors of the Company expire five years after the
date of grant.
56
<PAGE>
OPTIONS GRANTS IN THE LAST FISCAL YEAR
During the fiscal year ended June 30, 1998, there were no options granted under
the Company's 1991 Stock Option Plan to the Named Executive Officers.
The following table provides certain information with respect to options to
purchase Common Stock held by the Named Executive Officers at June 30, 1998.
<TABLE>
<CAPTION>
AGGREGATE OPTION EXERCISES IN FISCAL YEAR 1998 AND
1998 FISCAL YEAR END OPTION VALUES
Number of Securities Underlying Value of Unexercised In the Money
Unexercised Options at Fiscal Year End Options at Fiscal Year End
-------------------------------------- ---------------------------------
Name Exercisable Unexercisable Exercisable Unexercisable
---- ----------- ------------- ----------- -------------
<S> <C> <C> <C> <C>
Michael A. DeGiglio 275,208 44,792 $62,598 $ 6,152
Harold A. Joannidi 74,583 10,417 14,219 --
David W. Miller 87,500 17,500 25,938 --
</TABLE>
No options were exercised by the Named Executive Officers in fiscal year
1998.
57
<PAGE>
Item 12. Security Ownership of Certain Beneficial Owners and Management
- --------------------------------------------------------------------------------
SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth information regarding beneficial ownership
of the Common Stock as of October 2, 1998 by: (i) each person known to
EcoScience to be the beneficial owner of more than 5% of the Common Stock on
that date, (ii) each Director, (iii) each executive officer listed in the
Summary Compensation Table above and (iv) all Directors and executive officers
as a group.
<TABLE>
<CAPTION>
SUMMARY SECURITY OWNERSHIP TABLE
Shares Beneficially Percentage of
Name and Address Owned (1) (2) Total Shares
- ---------------- ------------------- -------------
<S> <C> <C>
Michael A. DeGiglio (3).............................................. 3,360,643 28.8%
Albert Vanzeyst (4).................................................. 2,941,811 25.3%
Thomas Montanti (5).................................................. 2,537,324 21.8%
David J. Ryan (6).................................................... 172,586 1.5%
Heinz K. Wehner (7).................................................. 8,000 *
Harold A. Joannidi (8)............................................... 17,000 *
David W. Miller (9).................................................. 25,772 *
All Directors and executive officers as a group
(9 persons) (10)............................................... 9,298,903 79.2%
</TABLE>
- ----------
*Less than 1%.
(1) Information with respect to beneficial ownership is based upon information
furnished to the Company by each stockholder included in this table. Except
as indicated in the notes to the table, each stockholder included in the
table has sole voting and investment power with respect to the shares shown
to be beneficially owned by him. Pursuant to the rules of the Securities
and Exchange Commission, shares of Common Stock which an individual or
member of a group has a right to acquire within 60 days of October 2, 1998
pursuant to the exercise of options or warrants are deemed to be
outstanding for the purpose of computing the percentage ownership of such
individual or group, but are not deemed to be outstanding for the purpose
of computing the percentage ownership of any other person shown in the
table.
(2) Information with respect to beneficial ownership reflect a one for five
reverse stock split and the issuance of 9,520,487 shares of Common Stock,
after giving effect to the reverse stock split; both actions were completed
pursuant to the Merger between EcoScience and APD, and both were effective
on September 30, 1998.
(3) Includes 166,593 shares held by Mr. DeGiglio's wife, as to which Mr.
DeGiglio disclaims beneficial ownership, 518,900 shares held in trust for
the benefit of Mr. DeGeglio's children that Mr. DeGiglio has no right to
vote and as to which he disclaims beneficial ownership, and 60,667 shares
issuable upon the exercise of stock options. Includes 3,287,011 shares
issued pursuant to the Merger between EcoScience and APD.
58
<PAGE>
(4) Includes 153,095 shares held in custody for Mr. Vanzeyst's child that Mr.
Vanzeyst has no right to vote and as to which he disclaims beneficial
ownership. Includes 2,941,811 shares issued pursuant to the Merger between
EcoScience and APD
(5) Includes 4,231 shares held by Mr. Montanti's wife, as to which Mr. Montanti
disclaims beneficial ownership. Includes 2,533,093 shares issued pursuant
to the Merger between EcoScience and APD.
(6) Includes 8,000 shares of Common Stock issuable upon exercise of warrants,
and 151,253 and 13,333 shares of Common Stock held and issuable upon
exercise of a warrant, respectively, by Copley Partners 2, L.P. Copley
Venture Partners L.P., a limited partnership of which Mr. Ryan is a general
partner, is a general partner of Copley Partners 2, L.P.
(7) Consists solely of shares of Common Stock issuable upon exercise of
warrants.
(8) Includes 17,000 shares of Common Stock issuable upon exercise of stock
options.
(9) Includes 21,000 shares of Common Stock issuable upon exercise of stock
options.
(10) Includes an aggregate for 128,000 shares of Common Stock issuable upon
exercise of stock options and warrants. Share amount includes 151,253 and
13,333 shares of Common Stock held and issuable upon exercise of a warrant,
respectively, by Copley Partners 2, L.P., for a total of 164,586 shares or
1.4% of total shares of Common Stock outstanding. Copley Venture Partners
L.P., a limited partnership of which Mr. Ryan is a general partner, is a
general partner of Copley Partners 2, L.P. Includes 8,997,682 shares issued
pursuant to the Merger between EcoScience and APD.
The mailing address for each of the persons listed above whose address was not
supplied in the table is c/o EcoScience Corporation, 10 Alvin Court, East
Brunswick, New Jersey 08816
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Securities Exchange Act of 1934, as amended, requires
directors, executive officers and persons who are beneficial owners of more than
ten percent of the Company's Common Stock to file with the Securities and
Exchange Commission (the "Commission") reports of their ownership of the
Company's securities and of changes in that ownership. To the Company's
knowledge, based on a review of copies of reports filed with the Commission and
written representations by certain reporting persons that no reports on Form 5
were required from those persons, all reports that were required to be filed
under Section 16(a) were timely filed.
Item 13. Certain Relationships and Related Transactions
Certain Transactions
Kenneth S. Boger, a Director of the Company until September 1998, is a
partner in the law firm of Warner & Stackpole LLP, which performed legal
services for the Company during fiscal 1998 and is expected to perform such
services in the current fiscal year. Legal fees paid to Warner & Stackpole LLP
in fiscal year 1998 totaled $120,000, net of disbursements.
59
<PAGE>
Prior to the Merger, Michael A. DeGiglio, President, Chief Executive
Officer and a director of the Company owned beneficially (or may have been
deemed to own beneficially) 366,075 shares of Common Stock representing 3.4% of
the outstanding capital stock of the Company. Mr. DeGiglio was also Chief
Executive Officer and a Director of APD; he served as its President until
January, 1997. Prior to the Merger Mr. DeGiglio owned beneficially approximately
106 shares of the Common Stock of APD, representing 34.5% of the outstanding
capital stock thereof. As of the effective date of the Merger and after giving
effect to the Reverse Split, Mr. DeGiglio owns beneficially (or may be deemed to
own beneficially) approximately 3,360,643 shares of the Common Stock of the
Company, representing 28.8% of the outstanding Common Stock of the Company.
Prior to the Merger Albert Vanzeyst, a stockholder, director and executive
officer of APD owned beneficially approximately 95 shares of the Common Stock of
APD, representing 30.9% of the outstanding capital stock thereof. As of the
effective date of the Merger, and after giving effect to the Reverse Split, Mr.
Vanzeyst owns beneficially approximately 2,941,811 shares of the Common Stock of
the Company, representing 25.3% of the outstanding Common Stock of the Company.
Also as of the effective date of the Merger, Mr. Vanzeyst became a director and
Executive Vice President of the Company.
Prior to the Merger, Thomas Montanti, a stockholder, director and Chairman
of the Board of APD owned beneficially approximately 82 shares of the Common
Stock of APD, representing 26.5% of the outstanding capital stock thereof. As of
the effective date of the Merger, and giving effect to the Reverse Split, Mr.
Montanti owns beneficially approximately 2,537,324 shares of the Common Stock of
the Company, representing 21.8% of the outstanding Common Stock of the Company.
Also as of the effective date of the Merger, Mr. Montanti became a director of
the Company.
Prior to the Merger, J. Kevin Cobb, a stockholder and Senior Vice President
Corporate Development of APD owned beneficially 7 7/10 shares of the Common
Stock of APD, representing 2.5% of the outstanding capital stock thereof. As of
the effective date of the Merger, and after giving effect to the Reverse Split,
Mr. Cobb owns beneficially approximately 235,767 shares of the Common Stock of
the Company, representing 2.0% of the outstanding Common Stock of the Company.
Also as of the effective date of the Merger, Mr. Cobb became Senior Vice
President - Corporate Development of the Company.
The Company sold products to APD, its largest customer, in the amount of
$5,012,000 or 22% of products sales for fiscal year ended June 30,1998 and
$2,954,000 or 14% of products sales for the fiscal year ended June 30, 1997. The
Company primarily sold the following products to APD during the fiscal years
ended June 30, 1998 and1997:
1) Fixed assets - Sorting, Grading and Packing systems, ISYS systems,
cart systems and a water transport system.
2) Growing systems based on Grodania A/S's Stonewool(R) inert growing
medium and seed.
3) Multiple greenhouse consumable products, including clips, hooks, twine
and covering material.
60
<PAGE>
Product purchases by APD frequently occur under standard purchase orders
issued for each shipment; certain larger dollar purchases of systems and
equipment may occur under individual contract. Material contracts and purchase
orders between APD and the Company fall into the following categories:
Irrigation Systems Contracts: Seven contracts provide for delivery of
irrigation systems to the Buffalo, Fort Davis, Marfa, Virginia and Wheatfield
facilities. Aggregate consideration is approximately $1,800,000. Terms of
payment generally provide for a deposit upon signing of the sales contract and
additional installment payments upon completion of certain specified milestones.
Several of the contracts also provide for training of personnel on computer
systems related to the irrigation systems.
Sorting, Grading & Packing Systems Purchase Orders: Five purchase orders
provide for delivery of Sorting, Grading & Packing systems to the Buffalo, Fort
Davis, Keystone, Marfa and Virginia facilities for aggregate consideration of
approximately $1,500,000. The purchase orders specify payment of a deposit prior
to shipping and additional installment payments upon delivery, installation, and
other specified milestones.
The Company and APD share certain facilities and other costs for which the
Company charged APD $42,000 and $39,000 for the fiscal years ended June 30, 1998
and 1997, respectively. The shared facilities currently consist of two
facilities the Company leases in New Jersey. APD is charged occupancy costs,
including facility lease, utilities and other costs, based on their
proportionate occupancy and usage. In addition, certain employees of each
company perform shared duties. Each of the Company and APD contributes that
portion of each such employee's salary that reflects the proportionate amount of
work done for that entity.
The Company management believes that prices and fees charged to APD for
products, facilities, and costs have been consistent with what would be charged
in arm's length transactions.
61
<PAGE>
Part IV
================================================================================
Item 14. Exhibits, Financial Statements and Reports on Form 8-K
(a)(1) The following consolidated financial statements of the Company and its
subsidiaries for the years ended June 30, 1998, 1997 and 1996, are
included at the pages indicated below:
Page
Consolidated Balance Sheets.........................................27
As of June 30, 1998 and 1997
Consolidated Statements of Operations...............................28
For the Years Ended June 30, 1998, 1997 and 1996
Consolidated Statements of Changes in Stockholders' Investment......29
For the Years Ended June 30, 1998, 1997 and 1996
Consolidated Statements of Cash Flows...............................30
For the Years Ended June 30, 1998, 1997 and 1996
Notes to Consolidated Financial Statements..........................31
Report of Independent Public Accountants............................50
(a)(2) There are no consolidated financial statement schedules required to be
presented herein:
All other schedules for which provision is made in the applicable
accounting regulations of the Securities and Exchange Commission are
not required under the related instructions or are not applicable, and
therefore have been omitted.
(a)(3) The following Exhibits are included in this Annual Report on Form
10-K:
Exhibit Exhibit
Number Description
- ------- ----------------------------------------------------------------------
2.1 Amended and Restated Agreement and Plan of Merger dated as of July 31,
1998 among EcoScience Corporation, Agro Acquisition Corporation and
Agro Power Development, Inc. [incorporated herein by reference to the
Registrant's Proxy Statement dated August 10, 1998 - Appendix A].
3.1 Restated Certificate of Incorporation of the Registrant dated June 29,
1988 [incorporated by reference to Exhibit 3.1 to the Registrant's
Annual Report on Form 10-K for the fiscal year ended June 30, 1992].
62
<PAGE>
Exhibit Exhibit
Number Description
- ------ ----------------------------------------------------------------------
3.2 By-Laws of the Registrant [incorporated by reference to Exhibit 3.2 to
the Registrant's Registration Statement on Form S-1, Registration
Statement No. 33-44664].
3.3 Certificate of Amendment of Restated Certificate of Incorporation of
the Registrant dated September 28, 1998. [filed herewith].
4.1 Specimen Common Stock Certificate of the Registrant [incorporated by
reference to Exhibit 4.1 to the Registrant's Registration Statement on
Form S-1, Registration Statement No. 33-44664].
4.2 Registration Rights Agreement between EcoScience Corporation and the
Shareholders identified on Schedule I thereto dated September 30,
1998. [filed herewith].
10.1* Registrant's 1991 Stock Option Plan, As Amended [incorporated by
reference to Exhibit 10.1 to the Registrant's Registration Statement
on Form S-1, Registration Statement No. 33-44664].
10.2* Registrant's 1988 Stock Option Plan [incorporated by reference to
Exhibit 10.2 to the Registrant's Registration Statement on Form S-1,
Registration Statement No. 33-44664].
10.3* Form of Non-Statutory Stock Option Agreement [incorporated by
reference to Exhibit 10.3 to the Registrant's Registration Statement
on Form S-1, Registration Statement No. 33-44664].
10.4 Common Stock Purchase Warrant between the Registrant and Copley
Partners 2, L.P., dated December 6, 1989, as amended [incorporated by
reference to Exhibit 10.8 to the Registrant's Annual Report on Form
10-K for the fiscal year ended June 30, 1993].
10.5 8% Convertible Preferred Stock Purchase Agreement between the
Registrant and the other parties named therein, dated June 29, 1988,
amended and restated on December 6, 1989, and amended June 7, 1991 and
July 30, 1991[incorporated by reference to Exhibit 10.5 to the
Registrant's Registration Statement on Form S-1, Registration
Statement No. 33-44664].
10.6 Preferred Stock Purchase Agreement between the Registrant and the
other parties named therein, dated June 7, 1991, and amended as of
July 30, 1991 [incorporated by reference to Exhibit 10.6 to the
Registrant's Registration Statement on Form S-1, Registration
Statement No. 33-44664].
* Indicates a management contract or compensatory plan or arrangement
required to be filed pursuant to Item 14(c) of Form 10-K.
63
<PAGE>
Exhibit Exhibit
Number Description
- ------- ----------------------------------------------------------------------
10.7 Series B Preferred Stock Purchase Agreement between the Registrant and
the other parties named therein, dated July 30, 1991, and amended on
October 31, 1991 [incorporated by reference to Exhibit 10.7 to the
Registrant's Registration Statement on Form S-1, Registration
Statement No. 33-44664].
10.8 Common Stock Warrant between the Registrant and E. Andrews Grinstead
III, dated May 22, 1991, as amended [incorporated by reference to
Exhibit 10.9 to the Registrant's Annual Report on Form 10-K for the
fiscal year ended June 30, 1993].
10.10 Common Stock Purchase Warrant between the Registrant and E. Andrews
Grinstead, III, dated June 7, 1991, as amended [incorporated by
reference to Exhibit 10.11 to the Registrant's Annual Report on Form
10-K for the fiscal year ended June 30, 1993].
10.14 Letter Agreement between the Registrant and Dr. and Mrs. Meir Broza,
dated November 4, 1991 [incorporated by reference to Exhibit 10.19 to
the Registrant's Registration Statement on Form S-1, Registration
Statement No. 33-44664].
10.15 Assignment of Patent Rights, dated November 7, 1991 [incorporated by
reference to Exhibit 10.20 to the Registrant's Registration Statement
on Form S-1, Registration Statement No. 33-44664].
10.16 Option to Purchase Common Stock between the Registrant and Dr. Meir
Broza, dated November 4, 1991 [incorporated by reference to Exhibit
10.21 to the Registrant's Registration Statement on Form S-1,
Registration Statement No. 33-44664].
10.20 Cooperative Research and Development Agreement between the Registrant
and the United States Department of Agriculture, dated July 10, 1990
[incorporated by reference to Exhibit 10.26 to the Registrant's
Registration Statement on Form S-1, Registration Statement No.
33-44664].
10.21 Product Development and License Agreement between the Registrant and
The Terminix International Company, L.P., dated as of June 3, 1992,
with certain confidential material omitted [incorporated by reference
to Exhibit 10.38 to the Registrant's Annual Report on Form 10-K for
the fiscal year ended June 30, 1992].
10.22 Agreement and Plan of Reorganization dated as of November 18, 1992,
among the Registrant, Agro Dynamics, Inc., Eco Acquisition Corporation
and the Stockholders named therein [incorporated by reference to
Exhibit 4.1 to the Registrant's Registration Statement on Form S-3,
Registration Statement No. 33-58540].
64
<PAGE>
Exhibit Exhibit
Number Description
- ------- ----------------------------------------------------------------------
10.23 Sublicense Agreement between the Registrant, J.R. Brooks & Sons., Inc.
and Seald-Sweet Growers, Inc., dated as of June 23, 1993, with certain
confidential material omitted [incorporated by reference to Exhibit
10.34 to the Registrant's Annual Report on Form 10-K for the fiscal
year ended June 30, 1993].
10.24 Agreement between Agro Dynamics, Inc. and Grodania A/S with certain
confidential material omitted [incorporated by reference to Exhibit
10.35 to the Registrant's Annual Report on Form 10-K for the fiscal
year ended June 30, 1993].
10.25 Lease between the Registrant and Worcester Business Development
Corporation, dated as of May 28, 1993 [incorporated by reference to
Exhibit 10.36 to the Registrant's Annual Report on Form 10-K for the
fiscal year ended June 30, 1993].
10.26 Form of Warrant issued to Directors of the Registrant [incorporated by
reference to Exhibit 10.38 to the Registrant's Annual Report on Form
10-K for the fiscal year ended June 30, 1993].
10.28 Asset Purchase Agreement, dated as of March 2, 1994, by and among the
Registrant, American Machinery Corporation and Aeroglide Corporation
[incorporated by reference to Exhibit 4.2 to the Registrant's
Registration Statement on Form S-3, Registration Statement No.
33-83184].
10.29 Master Equipment Lease Agreement, dated as of June 7, 1994, between
the Registrant and Financing For Science International, Inc.
[incorporated by reference to Exhibit 10.34 to the Registrant's Annual
Report on Form 10-K for the fiscal year ended June 30, 1994].
10.30 Loan Agreement dated as of October 28, 1994 by and among the
Registrant, Agro Dynamics, Inc., Agro Dynamics Canada Inc. and Silicon
Valley Bank [incorporated by reference to Exhibit 10.35 to the
Registrant's Annual Report on Form 10-K for the fiscal year ended June
30, 1994].
10.31 Sublease Agreement dated as of November 1, 1994, between the
Registrant and Hybridon, Inc. [incorporated by reference to Exhibit
10.32 to the Registrant's Annual Report on Form 10-K/A-2 for the
fiscal year ended June 30, 1995].
10.32 Marketing and Distribution Agreement dated as of May 15, 1995 between
Registrant and Rhone-Poulenc Agrichimie. [incorporated by reference to
Exhibit 10.33 to the Registrant's Annual Report on Form 10-K/A-2 for
the fiscal year ended June 30, 1995].
10.33 Distribution Agreement dated as of August 1, 1995, by and among Agro
Dynamics, Inc., Aweta, BV and Autoline. [incorporated by reference to
Exhibit 10.34 to the Registrant's Annual Report on Form 10-K/A-2 for
the fiscal year ended June 30, 1995].
65
<PAGE>
Exhibit Exhibit
Number Description
- ------ ----------------------------------------------------------------------
10.34 Distributorship Agreement dated as of September 25, 1995, between Agro
Dynamics, Inc. and H. Hoogendoorn Automation B.V. [incorporated by
reference to Exhibit 10.35 to the Registrant's Annual Report on Form
10-K/A-2 for the fiscal year ended June 30, 1995].
10.35 Partial Lease Termination Agreement for Massachusetts Biotechnology
Research Park Space dated as of September 19, 1995, between the
Registrant and Worcester Business Development Corporation.
[incorporated by reference to Exhibit 10.36 to the Registrant's Annual
Report on Form 10-K/A-2 for the fiscal year ended June 30, 1995].
10.36 Lease Termination Agreement dated as of September 29, 1995, between
the Registrant and Worcester Business Development Corporation.
[incorporated by reference to Exhibit 10.37 to the Registrant's Annual
Report on Form 10-K/A-2 for the fiscal year ended June 30, 1995].
10.37 Amendment of Sublease dated as of October 11, 1995, between the
Registrant and Hybridon, Inc. [incorporated by reference to Exhibit
10.38 to the Registrant's Annual Report on Form 10-K/A-2 for the
fiscal year ended June 30, 1995].
10.38 Loan Modification Agreement dated as of October 5, 1995, by and among
the Registrant, Agro Dynamics, Inc., Agro Dynamics Canada Inc., and
Silicon Valley Bank. [incorporated by reference to Exhibit 10.39 to
the Registrant's Annual Report on Form 10-K/A-2 for the fiscal year
ended June 30, 1995].
10.39 Agreement dated as of October 11, 1995 modifying the Master Equipment
Lease between the Registrant and Financing For Science International,
Inc. [incorporated by reference to Exhibit 10.40 to the Registrant's
Annual Report on Form 10-K/A-2 for the fiscal year ended June 30,
1995].
10.40 Lease Termination Agreement dated as of January 11, 1996 between the
Registrant and Worcester Business Development Corporation
[incorporated by reference to Exhibit 10.41 to the Registrant's
Current Report on Form 8-K dated January 16, 1996].
10.41 Debt Settlement Agreement dated as of February 20, 1996, by and among
the Registrant, EcoScience Produce Systems Corp., Aeroglide
Corporation of Florida and Aeroglide Corporation [incorporated by
reference to Exhibit 10.42 to the Registrant's Current Report on Form
8-K dated March 20, 1996].
10.42 Loan Modification Agreement dated as of July 5, 1996, by and among the
Registrant, Agro Dynamics, Inc., Agro Dynamics Canada Inc., and
Silicon Valley Bank [Incorporated by reference to Exhibit 10.42 to
Registrant's Annual Report on Form 10-K for fiscal year ended June 30,
1996].
66
<PAGE>
Exhibit Exhibit
Number Description
- ------ ----------------------------------------------------------------------
10.43 Loan Modification Agreement dated as of September 5, 1996, by and
among the Registrant, Agro Dynamics, Inc., Agro Dynamics Canada Inc.,
and Silicon Valley Bank [Incorporated by reference to Exhibit 10.43 to
Registrant's Annual Report on Form 10-K for fiscal year ended June 30,
1996].
10.44 Loan Modification Agreement dated as of October 5, 1996, by and among
the Registrant, Agro Dynamics, Inc., Agro Dynamics Canada Inc., and
Silicon Valley Bank [Incorporated by reference to Exhibit 10.44 to
Registrant's Annual Report on Form 10-K for fiscal year ended June 30,
1996].
10.45 Private Placement Memorandum dated September 20, 1996 for Offering of
Registrant's Common Stock [Incorporated by reference to Exhibit 10.45
to Registrant's Annual Report on Form 10-K for fiscal year ended June
30, 1996].
10.47 Master Equipment Lease Settlement Agreement dated as of August 8,
1996, between the Registrant and Financing For Science International,
Inc. [Incorporated by reference to Exhibit 10.47 to Registrant's
Annual Report on Form 10-K for fiscal year ended June 30, 1996].
10.48 Common Stock Warrant between the Registrant and Aeroglide Corporation
[Incorporated by reference to Exhibit 10.48 to Registrant's Annual
Report on Form 10-K for fiscal year ended June 30, 1996].
10.49 Form of Stock Purchase Agreement dated September 25, 1996, by and
among EcoScience Corporation, Taglich Brothers, D'Amadeo, Wagner &
Company, Incorporated, and other entities [Incorporated by reference
to Exhibit 10.49 to Registrant's Annual Report on Form 10-K for fiscal
year ended June 30, 1996].
10.50 Loan and Security Agreement dated as of April 28, 1997 by and among
the Registrant, Agro Dynamics, Inc., Agro Dynamics Canada Inc. and
EcoScience Produce Systems Corp. and Silicon Valley Bank.
[incorporated by reference to Exhibit 10.50 to the Registrant's
Quarterly Report on Form 10-Q for the Quarter Ended March 31, 1997].
10.51 Schedule to Loan and Security Agreement dated as of April 28, 1997 by
among the Registrant, Agro Dynamics, Inc., Agro Dynamics Canada Inc.
and EcoScience Produce Systems Corp. and Silicon Valley Bank.
[incorporated by reference to Exhibit 10.51 to the Registrant's
Quarterly Report on Form 10-Q for the Quarter Ended March 31, 1997].
67
<PAGE>
Exhibit Exhibit
Number Description
- ------ ----------------------------------------------------------------------
10.52 Continuing Guaranty by each of the Registrant, EcoScience Produce
Systems Corp. and Agro Dynamics, Inc. guaranteeing the obligations of
the Registrant, EcoScience Produce Systems Corp., Agro Dynamics, Inc.
and Agro Dynamics Canada Inc. in favor of Silicon Valley Bank.
[incorporated by reference to Exhibit 10.52 to the Registrant's
Quarterly Report on Form 10-Q for the Quarter Ended March 31, 1997].
10.53 Continuing Guarantee by Agro Dynamics Canada Inc. guaranteeing the
obligations of the Registrant in favor of Silicon Valley Bank.
[incorporated by reference to Exhibit 10.53 to the Registrant's
Quarterly Report on Form 10-Q for the Quarter Ended March 31, 1997].
10.54 Collateral Assignment, Patent Mortgage and Security Agreement by and
between EcoScience Corporation (Assignor) and Silicon Valley Bank
(Assignee). [incorporated by reference to Exhibit 10.54 to the
Registrant's Quarterly Report on Form 10-Q for the Quarter Ended March
31, 1997].
10.55 Collateral Assignment, Patent Mortgage and Security Agreement by and
between EcoScience Produce Systems Corp. (Assignor) and Silicon Valley
Bank (Assignee). [incorporated by reference to Exhibit 10.55 to the
Registrant's Quarterly Report on Form 10-Q for the Quarter Ended March
31, 1997].
10.56 Collateral Assignment, Patent Mortgage and Security Agreement by and
between Agro Dynamics, Inc. (Assignor) and Silicon Valley Bank
(Assignee). [incorporated by reference to Exhibit 10.56 to the
Registrant's Quarterly Report on Form 10-Q for the Quarter Ended March
31, 1997].
10.57 Agreement between Agro Dynamics, Inc. and Grodania A/S, dated
September 29, 1997, with certain confidential material omitted.
[incorporated by reference to Exhibit 10.57 to the Registrant's Form
10-Q for the Quarter Ended September 30, 1997].
10.58 Letter of Intent to Merge between EcoScience Corporation and Agro
Power Development, Inc. dated November 20, 1997. [incorporated by
reference to Exhibit 10.58 to the Registrant's Form 8-K dated November
20, 1997].
10.59 Amendment to Loan Documents dated September 25, 1998, by and among the
Registrant, EcoScience Produce Systems Corp., Agro Dynamics, Inc.,
Agro Dynamics Canada Inc. and Silicon Valley Bank. [ filed herewith].
20.1 Press Release dated November 20, 1997, announcing the Registrant's
intent to merge with Agro Power Development, Inc. [incorporated by
reference to Exhibit 20.1 to the Registrant's Form 8-K dated November
20, 1997].
68
<PAGE>
Exhibit Exhibit
Number Description
- ------ ----------------------------------------------------------------------
20.2 Press Release dated April 29, 1998, announcing the Registrant and Agro
Power Development, Inc. signing a Definitive Merger Agreement.
[incorporated by reference to Exhibit 20.2 to the Registrant's Form
8-K dated April 29, 1998].
21 Subsidiaries of the Registrant [filed herewith].
23 Consent of Arthur Andersen LLP [filed herewith].
24 Powers of Attorney of officers and directors of the Company [included
in the signature page filed on October 12, 1998].
27 Financial Data Schedule for the Fiscal Year Ended June 30, 1998 [filed
herewith]
(b) Reports on Form 8-K
Report dated April 29, 1998, which incorporated a press release dated
April 29, 1998, announcing that the Registrant and Agro Power
Development, Inc. signed a Definitive Merger Agreement.
Note: [None of the Exhibits listed in the foregoing index is included with
this Annual Report on Form 10-K for the fiscal year ended June 30,
1998. A copy of these Exhibits may be obtained without charge by
writing to Harold A. Joannidi, EcoScience Corporation, 10 Alvin Court,
East Brunswick, NJ 08816.]
69
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized in the City of East
Brunswick, the State of New Jersey, on October 12, 1998.
ECOSCIENCE CORPORATION
By: /s/ Michael A. DeGiglio
-----------------------
Michael A. DeGiglio
President and Chief Executive Officer
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature
appears below on this report hereby constitutes and appoints Michael A. DeGiglio
and Harold A. Joannidi, and each of them with full power to act without the
other, his true and lawful attorney in fact and agent, with full power of
substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities to sign any and all amendments to this report, and to
file the same, with all exhibits hereto, and other documents in connection
herewith, with the Securities and Exchange Commission, granting unto said
attorneys in fact and agents, and each of them, full power and authority to do
and perform each and every act and thing, ratifying and confirming all that said
attorneys in fact and agents or any of them or their or his substitute or
substitutes, may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.
Name Title Date
- ---- ----- ----
/s/ Michael A. DeGiglio President, Chief Executive October 12, 1998
- ----------------------- Officer and Director
Michael A. DeGiglio
/s/ Harold A. Joannidi Treasurer, Secretary and October 12, 1998
- ----------------------- Corporate Controller
Harold A. Joannidi
/s/ Thomas Montanti Director October 12, 1998
- -----------------------
Thomas Montanti
70
<PAGE>
Name Title Date
- ---- ----- ----
/s/ David J. Ryan Chairman of the Board October 12, 1998
- -----------------------
David J. Ryan
/s/ Albert Vanzeyst Executive Vice President and October 12, 1998
- ----------------------- Director
Albert Vanzeyst
/s/ Heinz K. Wehner Director October 12, 1998
- -----------------------
Heinz K. Wehner
71
<PAGE>
ECOSCIENCE CORPORATION
EXHIBIT INDEX
<TABLE>
<CAPTION>
Exhibit Number Description of Exhibit Page Number
- -------------- ---------------------- -----------
<S> <C> <C>
3.3 Certificate of Amendment of Restated Certificate of Incorporation of 73
the Registrant dated September 28, 1998.
4.2 Registration Rights Agreement between EcoScience Corporation and the 75
Shareholders identified on Schedule I thereto dated September 30,
1998.
10.59 Amendment to Loan Documents dated September 25, 1998, by and among the 89
Registrant, EcoScience Produce Systems Corp., Agro Dynamics,
Inc., Agro Dynamics Canada Inc. and Silicon Valley Bank.
21 Subsidiaries of the Registrant as of June 30, 1998 93
23 Consent of Independent Public Accountants 94
27 Financial Data Schedule as of and for the Year 95 Ended June 30, 1998 95
</TABLE>
72
<PAGE>
ECOSCIENCE CORPORATION
EXHIBIT 3.3
- --------------------------------------------------------------------------------
CERTIFICATE OF AMENDMENT
OF
RESTATED CERTIFICATE OF INCORPORATION
OF
ECOSCIENCE CORPORATION
EcoScience Corporation, a corporation organized and existing under and by
virtue of the General Corporation Law of the State of Delaware (the
"Corporation"), DOES HEREBY CERTIFY:
FIRST: That, at Special Meetings of the Board of Directors held on May 4,
1998 and May 11, 1998, resolutions proposing amendments to the Restated
Certificate of Incorporation, as amended as of the date hereof, (the
"Certificate") of the Corporation approving a one-for-five reverse split of the
Corporation's Common Stock, $.01 par value, and increasing the number of
authorized shares of capital stock, were duly adopted and declared to be
advisable.
SECOND: That, in accordance with Section 228 of the General Corporation Law
of the State of Delaware, the holders of a majority of the issued and
outstanding capital stock of the Corporation required to amend said Certificate
voted at a Special Meeting of the Stockholders of the Corporation held on
September 10, 1998, to approve such amendments. The resolutions setting forth
the amendment are as follows:
RESOLVED: That, upon the filing of a Certificate of Amendment with the
Office of the Secretary of State, State of Delaware (a) each five
(5) shares of the Corporation's outstanding common stock shall be
combined into one (1) share of common stock, (b) cash shall be
paid in lieu of fractional shares to holders of common stock who
would otherwise be entitled to receive fractional shares, and (c)
the par value per share shall remain at $.01.
FURTHER
RESOLVED: That Section 4.1 of Article IV of the Restated Certificate of
Incorporation of the Corporation is amended to provide in its
entirety as follows:
"Section 4.1. Total Number of Shares of Stock. The total number
of shares of all classes of stock which the Corporation has the
authority to issue is One Hundred Ten Million (110,000,000)
shares consisting of One Hundred Million shares of common stock,
$.01 par value per share (the
73
<PAGE>
"Common Stock"), and Ten Million (10,000,000) shares of preferred
stock, $.01 par value per share (the"Preferred Stock")."
FOURTH: That said amendments were duly adopted in accordance with the
provisions of Section 242 of the General Corporation Law of the State of
Delaware.
IN WITNESS WHEREOF, said EcoScience Corporation has caused its corporate
seal to be hereunto affixed and this certificate to be signed by Michael A.
DeGiglio, its President and Harold A. Joannidi, its Secretary, this 28th day of
September, 1998.
ECOSCIENCE CORPORATION
[SEAL]
By: /s/ Michael A. DeGiglio
------------------------------
Michael A. DeGiglio, President
/s/ Harold A. Joannidi
------------------------------
Harold A. Joannidi, Secretary
74
<PAGE>
ECOSCIENCE CORPORATION
EXHIBIT 4.2
- --------------------------------------------------------------------------------
REGISTRATION RIGHTS AGREEMENT
This Registration Rights Agreement (the "Agreement") made and entered into
as of September 30, 1998 by and among EcoScience Corporation, a Delaware
corporation (the "Company"), and the shareholders identified on Schedule I
hereto (each a "shareholder" and collectively, the "Stockholders").
WHEREAS, pursuant to the Amended and Restated Agreement and Plan of Merger
dated as of July 31, 1998, the Company issued an aggregate of 8,063,578 shares
of its common stock, $.01 par value (the "Common Stock") to the Stockholders;
and
WHEREAS, the parties hereto wish to set forth their agreement with respect
to certain matters relating to the registration of the Common Stock issued to
the Shareholders under federal and state securities laws;
NOW, THEREFORE, in consideration of the mutual promises contained herein,
the parties hereto hereby agree as follows:
1. Certain Definitions. As used herein, the following terms shall have the
following respective meanings:
(a) "Commission" shall mean the Securities and Exchange Commission, or any
other federal agency at the time administering the Securities Act.
(b) "Exchange Act" shall mean the Securities Exchange Act of 1934, as
amended, and the rules and regulations of the Commission thereunder,
all as the same shall be in effect at the time.
(c) "Person" means an individual, partnership, corporation, business
trust, joint stock company, trust, unincorporated association, joint
venture, governmental authority or other entity, of whatever nature.
(d) "Registrable Securities" shall mean the shares of Common Stock issued
to the Shareholders pursuant to the Merger Agreement; provided,
however, that Registrable Securities shall cease to be Registrable
Securities upon any sale pursuant to a registration statement under
the Securities Act or upon any sale to the public under Rule 144, or
any successor rule, promulgated by the Commission under the Securities
Act.
(e) "Registration Expenses" shall mean the expenses so described in
Section 7 hereof.
75
<PAGE>
(f) "Securities Act" shall mean the Securities Act of 1933, as amended,
and the rules and regulations of the Commission thereunder, all as the
same shall be in effect at the time.
(g) "Selling Expenses" shall mean the expenses so described in Section 7
hereof.
2. Restricted Legend. Each certificate representing Registrable Securities
and, except for certificates evidencing Registrable Securities which have
been sold pursuant to an effective registration statement under the
Securities Act or which may be publicly sold under Rule 144(k) promulgated
under the Securities Act, each certificate representing Registrable
Securities issued upon a subsequent exchange or transfer thereof shall be
stamped or otherwise imprinted with a legend substantially in the following
form:
"THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER ANY STATE SECURITIES
LAWS OR THE SECURITIES ACT OF 1933. THEY MAY NOT BE TRANSFERRED OR
OTHERWISE DISPOSED OF UNLESS THEY HAVE BEEN REGISTERED UNDER THAT ACT
OR ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM
REGISTRATION IS AVAILABLE. THESE SECURITIES ARE ALSO SUBJECT TO THE
TERMS AND PROVISIONS SET FORTH IN A CERTAIN REGISTRATION RIGHTS
AGREEMENT DATED SEPTEMBER 30, 1998, A COPY OF WHICH IS AVAILABLE FOR
INSPECTION AT THE OFFICES OF ECOSCIENCE CORPORATION.
3. Requested Registration on Form S-3.
(a) Request for Registration. If the Company shall receive from holders
who in the aggregate hold not less than twenty percent (20%) of the
Registrable Securities then outstanding (the "Requesting Holders") a
written request that the Company effect registration on Form S-3 with
respect to all or a part of the Registrable Securities, the Company
will:
(i) promptly give written notice of the requested registration to all
other holders of the Registrable Securities; and
(ii) as soon as practicable, use its diligent best efforts to effect
such registration (including, without limitation, the execution
of an undertaking to file post-effective amendments, appropriate
qualification under a reasonable number of jurisdictions'
applicable blue sky or other state securities laws and
appropriate compliance with applicable regulations issued under
the Securities Act) of (a) the Registrable Securities which the
Company has been so registered to include in such registration by
the Requesting Holders and (b) all other Registrable Securities
which the Company has been requested
76
<PAGE>
to include in the registration by the holders thereof within 15
days after the giving of such written notice by the Company, and
as would permit or facilitate the sale and distribution of all or
such portion of such Registrable Securities as are specified in
such requests; provided that the Company shall not be obligated
to effect, or to take any action to effect, any such registration
pursuant to this Section 3:
(A) On more than three occasions; provided, however, that if the holders
of Registrable Securities are unable to complete the sale of 75% or
more of the Registrable Securities for which registration has been
requested in an underwritten offering then such requested registration
shall be deemed not to have been effected.
(B) If the Company does not qualify for use of Form S-3 (or any successor
to such form); provided, however, that at all times during the term of
this Agreement, the Company shall use its best efforts to qualify for
the use of Form S-3 (or any successor to such form).
(C) If the Company, within ten (10) days of the receipt of the request of
the Requesting Holders, gives notice of its bona fide intention to
effect the filing of a registration statement with the Commission
within ninety (90) days of receipt of such request (other than with
respect to a registration statement relating to a Rule 145
transaction, an offering solely to employees or any other registration
which is not appropriate for the registration of Registrable
Securities).
(D) During the period starting with the date thirty (30) days prior to the
Company's estimated date of filing of, and ending on the date three
(3) months immediately following the effective date of, any
registration statement pertaining to an underwritten offering of
securities by the Company (other than a registration of securities in
a Rule 145 transaction or with respect to an employee benefit plan),
provided that the Company is actively employing in good faith all
reasonable efforts to cause such registration statement to become
effective.
(E) If the Company shall furnish to the Requesting Holders a certificate
signed by the President of the Company stating that in the good faith
judgment of the Board of Directors, the filing of a registration
statement by the Company in the near future would substantially
interfere with a significant transaction in which the Company is then
presently engaged or in which the Company proposes to engage, then the
77
<PAGE>
Company's obligation to use its best efforts to file a registration
statement shall be deferred for a period not to exceed 120 days from
the receipt of the request to file such registration by such
Requesting Holder or Holders, provided that the Company may not
exercise this deferral right more than once per twelve month period.
(F) With respect to Registrable Securities as to which registration rights
have not yet become available, as set forth in Section 10 hereof.
Subject to the foregoing clauses (A) through (F), the Company shall file a
registration statement on Form S-3 covering the Registrable Securities so
requested to be registered as soon as practicable after receipt of the
request.
(b) Underwriting. If the Requesting Holders intend to distribute the
Registrable Securities covered by its request by means of an underwriting,
they shall so advise the Company as a part of the request made pursuant to
Section 3. In the case of an underwritten offering to which this Section 3
shall apply, no securities other than the Registrable Securities shall be
included among the securities covered by such registration unless (i) the
managing underwriter of such offering shall have advised the Company in
writing that the inclusion of such other securities would not adversely
affect such offering or (ii) the holders of more than 50% of the
Registrable Securities for which registration has been requested shall have
consented in writing to the inclusion of such other securities. The Company
shall enter into an underwriting agreement in customary form with the
representative of the underwriter or underwriters selected for such
underwriting by the Registrable Holder.
(c) Priority in Demand Registration. If (i) a registration pursuant to this
Section 3 involves an underwritten offering of the securities so being
registered, (ii) the managing underwriter(s) of such underwritten offering
shall advise the Requesting Holders and/or the Company that, in its
opinion, the number of shares of Common Stock proposed to be sold in (or
during the time of) such offering would adversely affect the success of
such offering, then there shall be included in such registration only such
number of shares of Common Stock recommended by such managing underwriter
and (iii) the number of shares so included shall be allocated to the
holders of Registrable Securities requesting registration in proportion, as
nearly as practicable, to the total number of shares of Registrable
Securities held by such holders at the time of the filing of the
registration statement.
4. Incidental Registration.
(a) Request for Registration. If the Company at any time proposes to register
any of its securities under the Securities Act for sale, whether for its
own account or for the account of other security holders or both (except
with
78
<PAGE>
respect to (x) registration statements on Form S-8 or Form S-4 or their
then equivalent forms, or another form not available for registering the
Registrable Securities for sale to the public, (y) a registration relating
solely to employee benefit plans, or (z) a registration relating solely to
a Rule 145 transaction), it will each such time: (i) promptly give to the
holders of the Registrable Securities (hereinafter "holders") written
notice thereof (which shall include a list of the jurisdictions in which
the Company intends to attempt to qualify such securities under the
applicable blue sky or other state securities laws); and (ii) include in
such registration (and any related qualification under blue sky laws or
other compliance), and in any underwriting involved therein, all the
Registrable Securities specified in a written request made by a holder
within fifteen (15) days after receipt of the written notice from the
Company described in clause (i) above, except that the number of shares
included in such registration on behalf of a holder of Registrable
Securities, if any, shall be subject to the provisions set forth in Section
4(c) below. Such written request may specify all or a part of a holder's
Registrable Securities.
The Company shall not be obligated to effect, or to take any action to
effect, any registration of Registrable Securities as to which registration
rights have not yet become available, as set forth in Section 10 hereof.
(b) Underwritten Offerings. If the registration of which the Company gives
notice is for an underwritten offering of Common Stock, the Company shall
so advise the holders as a part of the written notice given pursuant to
Section 4(a). In such event, the right of such holders to registration
pursuant to Section 4(a) above shall be conditioned upon such holders'
participation in such underwriting. Each holder shall, if it proposes to
distribute Registrable Securities through such underwriting, (together with
the Company and other parties distributing securities through such
underwriting) enter into an underwriting agreement in customary form with
the managing underwriter(s) selected by the Company.
(c) Priority in Incidental Registrations. If (i) a registration pursuant to
this Section 4 involves an underwritten offering of the securities so being
registered, whether or not for sale for the account of the Company, and
(ii) the managing underwriters of such underwritten offering shall advise
the Company in writing that, in its opinion, the number of shares of Common
Stock (including Registrable Securities) proposed to be sold in (or during
the time of) such offering would adversely affect the success of such
offering, then the Company shall include in such registration only such
number of shares of Common Stock (including Registrable Securities)
recommended by such managing underwriter, selected in the following order
or priority: (i) first, all of the shares of Common Stock that the Company
proposes to sell for its own account, if any, and (ii) second, the
Registrable Securities requested to be included in such registration by the
holders of Registrable Securities (in proportion, as nearly as practicable,
to the total number of shares of Registrable Securities held by such
holders at the time of the filing
79
<PAGE>
of the registration statement); provided, however, that (x) if any equity
securities are proposed to be included in such offering for the account of
any person or persons other than the Company pursuant to rights to demand
registration the amount of Registrable Securities to be included therein
shall be pro rata with all other equity securities that have requested to
be included by the holder of such demand registration rights and (y) if any
equity securities are proposed to be included in such offering for the
account of any person or persons other than the Company pursuant to rights
of incidental registration similar to those provided in this Section 4, all
Registrable Securities to be included therein shall be included prior to
the inclusion of any other registrable equity securities that have
requested to be included.
5. Grant of Additional Rights. The Company may grant subsequent investors
rights of registration upon request (such as those provided in Section 3)
and rights of incidental registration (such as those provided in Section 4)
provided that (i) such rights are not inconsistent with the rights granted
pursuant to this Agreement, and (ii) the instrument granting such rights
specifically confirms the rights of the holders of the Registrable
Securities.
6. Registration Procedures. In the case of each registration effected by the
Company pursuant to Section 3 or 4, the Company will:
(a) keep such registration effective for a period of two hundred seventy
(270) days or until the sellers have completed the distribution
described in the registration statement relating thereto, whichever
first occurs;
(b) Prepare and file with the Commission such amendments and supplements
to such registration statement and the prospectus used in connection
with such registration statement as may be necessary to comply with
the provisions of the Securities Act with respect to the disposition
of all securities covered by such registration statement;
(c) furnish to each holder of Registrable Securities whose shares have
been included in the registration (each a "seller") and to each
underwriter such number of copies of the registration statement and
the prospectus included therein (including each preliminary
prospectus), as such persons may reasonably request in order to
facilitate the public sale or other disposition of the securities
covered by such registration statement;
(d) use its best efforts to register or qualify the Registrable Securities
covered by such registration statement under the securities or blue
sky laws of such jurisdictions as the sellers or, in the case of an
underwritten public offering, the managing underwriter(s), shall
reasonably request provided, however, that the Company shall not for
any such purpose be required to qualify generally to transact business
as a foreign corporation in any jurisdiction where it is not so
qualified, to amend its by-laws or to consent to general service of
process in any such jurisdiction;
80
<PAGE>
(e) immediately notify each seller and each underwriter at any time when a
prospectus relating thereto is required to be delivered under the
Securities Act, of the happening of any event as a result of which the
prospectus contained in such registration statement, as then in
effect, includes an untrue statement of a material fact or omits to
state any material fact required to be stated therein or necessary to
make the statements therein not misleading in the light of the
circumstances then existing, and at the request of the sellers,
prepare and furnish to the sellers a reasonable number of copies of a
supplement to or amendment of such prospectus as may be necessary so
that, as thereafter delivered to the purchasers of such shares, such
prospectus shall not include an untrue statement of a material fact or
omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading or incomplete
in the light of the circumstances then existing;
(f) cause all such Registrable Securities to be listed on each securities
exchange on which similar securities issued by the Company are then
listed;
(g) make available for inspection by sellers, any underwriter
participating in any disposition pursuant to such registration
statement, and any attorney, accountant or other agent retained by any
such seller or any such underwriter, all financial and other records,
pertinent corporate documents and properties of the Company, and cause
the Company's officers, directors and employees to supply all
information reasonably requested by sellers, underwriter, attorney,
accountant or agent in connection with such registration statement;
(h) furnish to sellers a signed counterpart, addressed to sellers, of (i)
an opinion of counsel for the Company, dated the effective date of the
registration statement, and (ii) "comfort" letters signed by the
Company's independent public accountants who have examined and
reported on the Company's financial statements included in the
registration statement, to the extent permitted by the standards of
the AICPA;
(i) furnish to sellers a copy of all documents filed with and all
correspondence from or to the Commission in connection with any such
offering;
(j) otherwise use its best efforts to comply with all applicable rules and
regulations of the Commission, and make available to its security
holders, as soon as reasonably practicable, an earnings statement
covering the period of at least twelve months, but not more than
eighteen months, beginning with the first month after the effective
date of the registration statement, which earnings statement shall
satisfy the provisions of Section 11(a) of the Securities Act; and
(k) in connection with any underwritten offering pursuant to a
registration statement filed pursuant to Section 3 hereof, the Company
will enter into any underwriting agreement reasonably necessary to
effect the offer and sale of Common Stock, provided such underwriting
agreement contains customary
81
<PAGE>
underwriting provisions including, without limitation, such provisions
regarding opinions of counsel for the Company as are reasonably
satisfactory to such counsel and provided further that if the
underwriter so requests the underwriting agreement will contain
customary contribution provisions.
7. Expenses. All expenses incurred by the Company in complying with Section 4
and 5 hereof, including without limitation all registration and filing
fees, printing expenses, fees and disbursements of counsel for the Company
and independent public accountants for the Company, blue sky fees and
expenses, fees of the National Association of Securities Dealers, Inc.,
reasonable fees and disbursements of one (1) counsel to sellers, fees and
expenses of transfer agents and registrars, but excluding any Selling
Expenses (as hereinafter defined), are herein called "Registration
Expenses". All underwriting discounts and selling commissions and expense
allowances payable to an underwriter applicable to the sale of Registrable
Securities are herein called "Selling Expenses". The Company will pay all
Registration Expenses in connection with each registration statement
pursuant to Section 4 hereof. All Selling Expenses in connection with any
registration statement filed pursuant to Section 3 or Section 4 hereof
shall be borne by the sellers (pro rata, based on the number of shares
included in the registration for the account of the sellers).
8. Indemnification.
(a) The Company will indemnify each seller with respect to which
registration, qualification or compliance has been effected pursuant
to this Agreement, and each underwriter, if any, and each Person who
controls any underwriter, against all claims, losses, damages and
liabilities (or actions, proceedings or settlements in respect
thereof) arising out of or based on any untrue statement (or alleged
untrue statement) of a material fact contained in any prospectus,
offering circular or other document (including any related
registration statement, notification or the like) incident to any such
registration, qualification or compliance, or based on any omission
(or alleged omission) to state therein a material fact required to be
stated therein or necessary to make the statements therein not
misleading, or any violation by the Company of the Securities Act or
the Exchange Act or any rule or regulation thereunder applicable to
the Company and relating to action or inaction required of the Company
in connection with any such registration, qualification or compliance,
and will reimburse each seller for any legal and any other expenses
reasonably incurred in connection with investigating and defending or
settling any such claim, loss, damage, liability or action, provided
that the Company will not be liable in any such case to the extent
that any such claim, loss, damage, liability or expense arises out of
or is based on any untrue statement or omission based upon written
information furnished to the Company by a seller or underwriter and
stated to be specifically for use therein.
82
<PAGE>
(b) Each seller will, if Registrable Securities held by it are included in
the securities as to which such registration, qualification or
compliance is being effected, indemnify the Company, each of its
directors, officers and employees and each underwriter, if any, of the
Company's securities covered by such a registration statement, and
each Person who controls the Company or such underwriter, against all
claims, losses, damages and liabilities (or actions in respect
thereof) arising out of or based on any untrue statement (or alleged
untrue statement) of a material fact contained in any such
registration statement, prospectus, offering circular or other
document, or any omission (or alleged omission) to state therein a
material fact required to be stated therein or necessary to make the
statements therein not misleading or any violation by such seller of
the Securities Act or the Exchange Act or any rule or regulation
thereunder applicable to such seller and relating to action in
inaction required of seller in connection with any such registration,
qualification or compliance, and will reimburse the Company, each of
its officers, directors and employees, and each Person who controls
the Company, each such underwriter and each Person who controls any
such underwriter for any legal or any other expenses reasonably
incurred in connection with investigating and defending or setting
such claim, loss, damage, liability or action, in each case to the
extent, but only to the extent, that such untrue statement (or alleged
untrue statement) or omission (or alleged omission) is made in such
registration statement, prospectus, offering circular or other
document in reliance upon and in conformity with written information
furnished to the Company by such seller and stated to be specifically
for use therein; provided, however, that the obligations of seller
hereunder shall be limited to an amount equal to the proceeds to
seller of securities sold as contemplated herein.
(c) Each party entitled to indemnification under this Section 8 (the
"Indemnified Party") shall give notice to the party required to
provide indemnification (the "Indemnifying Party") promptly after such
Indemnified Party has actual knowledge of any such claim as to which
indemnity may be sought, and shall permit the Indemnifying Party to
assume the defense of any such claim or any litigation resulting
therefrom, provided that counsel for the Indemnifying Party, who shall
conduct the defense of such claim or any litigation resulting
therefrom, shall be approved by the Indemnified Party (whose approval
shall not unreasonably be withheld), and the Indemnified Party may
participate in such defense at such party's expense, and provided
further that the failure of any Indemnified Party to give notice as
provided herein shall not relieve the Indemnifying Party of its
obligations under this Section 8 provided that such failure does not
prejudice the Indemnifying Party. No Indemnifying Party, in the
defense of any such claim or litigation, shall, except with the
consent of each Indemnified Party, consent to entry of any judgment or
enter into any settlement which does not include as an unconditional
term thereof the giving by the claimant or plaintiff to such
Indemnified Party of a release from all liability in respect to such
claim or litigation. Each Indemnified Party shall furnish such
information regarding itself or the claim in question as an
83
<PAGE>
Indemnifying Party may require in connection with defense of such
claim and litigation resulting therefrom.
(d) Contribution. If recovery is not available under the foregoing
indemnification provisions of Section 8, for any reason other than as
specified therein, the parties entitled to indemnification by the
terms thereof shall be entitled to contribution to liabilities and
expenses. In determining the amount of contribution to which the
respective parties are entitled, there shall be considered the
relative benefits received by each party from the offering of the
securities (taking into account the portion of the proceeds of the
offering realized by each), the parties' relative knowledge and access
to information concerning the matter with respect to which the claim
was asserted, the opportunity to correct and prevent any statement or
omission and any other equitable considerations appropriate under the
circumstances. Notwithstanding the provisions of this Section 8, no
person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act), shall be entitled to
contribution from any person who is not guilty of such fraudulent
misrepresentation.
9. Information by Sellers. Each seller shall furnish to the Company such
information regarding such seller and the distribution proposed by such
seller as the Company may reasonably request in writing and as shall be
reasonably required in connection with any registration, qualification or
compliance referred to in this Agreement.
10. Effectiveness of Registration Rights. Holders of Registrable Securities
shall have the right to request registration of any of the Registrable
Securities pursuant to the terms of this Agreement as follows:
(a) 25% of the Registrable Securities issued to Thomas Montanti on or
after March 30, 1999;
(b) 25% of the Registrable Securities issued to each of the Stockholders
other than Thomas Montanti on or after September 30, 1999;
(c) An additional 25% of the Registrable Securities issued to each of the
Stockholders on or after March 30, 2000;
(d) All other Registrable Securities on or after September 30, 2000.
11. Rule 144 Reporting. With a view to making available the benefits of certain
rules and regulations of the Commission which may permit the sale of the
Registrable Securities to the public without registration, the Company
agrees to:
(a) Make and keep public information available as those terms are
understood and defined in Rule 144 under the Securities Act;
84
<PAGE>
(b) Use its best efforts to file with the Commission in a timely manner
all reports and other documents required of the Company under the
Securities Act and the Exchange Act; and
(c) Furnish to each holder of Registrable Securities forthwith upon
request a written statement by the Company as to its compliance with
the reporting requirements of Rule 144, and of the Securities Act and
the Exchange Act, a copy of the most recent annual or quarterly report
of the Company, and such other reports and documents so filed as such
holder may reasonably request in availing itself of any rule or
regulation of the Commission allowing such holder to sell any such
securities without registration.
12. Changes in Common Stock. If, and as often as, there are any changes in the
Common Stock by way of stock split, combination, reclassification, stock
dividend or through merger, consolidation, reorganization or
recapitalization, appropriate adjustment shall be made in the provisions
hereof so that the rights and privileges granted hereby shall continue with
respect to the Common Stock as so changed.
13. Transfer or Assignment of Registration Rights. The rights to cause the
Company to register securities granted to Stockholders by the Company
hereunder may be transferred or assigned by each Stockholder to a
transferee or assignee of any Registrable Securities, provided that:
(a) The Company is given written notice at the time of or within a
reasonable time after said transfer or assignment, stating the name
and address of said transferee or assignee and identifying the
securities with respect to which such registration rights are being
transferred or assigned; and
(b) The transferee or assignee of such rights assumes, in writing, the
obligations of the assigning Stockholder under this Agreement.
14. Miscellaneous.
(a) All covenants and agreements contained in this Agreement by or on
behalf of any of the parties hereto shall bind and inure to the
benefit of the respective successors and assigns of the parties hereto
whether so expressed or not. Without limiting the generality of the
foregoing and subject to Section 13 hereof, the registration rights
conferred herein on the Stockholders shall inure to the benefit of the
holders from time to time of the Registrable Securities.
(b) All notices, requests, consents and other communications hereunder
shall be in writing and shall be mailed by first class registered or
certified mail, postage prepaid, or by overnight courier guaranteeing
next day delivery and requiring a signature upon delivery, addressed
as follows:
if to the Company, to it at its office at 10 Alvin Court, East
Brunswick, New Jersey 08816;
85
<PAGE>
if to a Stockholder at his address set forth on Schedule I hereto;
if to any subsequent holder of Registrable Securities, to it at such
address as may have been furnished to the Company in writing by such
holder;
or, in any case, at such other address or addresses as shall have been
furnished in writing to the Company (in the case of a holder of
Registrable Securities) or to the holders of Registrable Securities
(in the case of the Company).
All such notices, requests, consents and other communications shall be
deemed to have been delivered (a) in the case of overnight courier, on
the business day following the date of dispatch and (b) in the case of
mailing, on the third business day following such mailing.
(c) This Agreement shall be governed by and construed in accordance with
the laws of the State of Delaware.
(d) This Agreement constitutes the entire agreement of the parties with
respect to the subject matter hereof and may not be modified or
amended except by an instrument in writing signed by the Company and
each holder of Registrable Securities.
(e) This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall
constitute one and the same instrument.
(f) This Agreement contains the entire agreement among the parties with
respect to the subject matter hereof and supersedes all prior
arrangements or understandings with respect hereto.
(g) The headings of the various sections of this Agreement have been
inserted for convenience of reference only and shall not be deemed to
be a part of this Agreement.
(h) It is the desire and intent of the parties that the provisions of this
Agreement be enforced to the fullest extent permissible under the law
and public policies applied in each jurisdiction in which enforcement
is sought. Accordingly, if any provision of this Agreement would be
held in any jurisdiction to be invalid, prohibited or unenforceable
for any reason, such provision, as to such jurisdiction, shall be
ineffective, without invalidating the remaining provisions of this
Agreement or affecting the validity or enforceability of such
provision in any other jurisdiction. Notwithstanding the foregoing, if
such provision could be more narrowly drawn so as not to be invalid,
prohibited or unenforceable in such jurisdiction, it shall, as to such
jurisdiction, be so narrowly drawn, without invalidating the remaining
provisions of this Agreement or affecting the validity or
enforceability of such provision in any other jurisdiction.
86
<PAGE>
IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
first above written.
ATTEST: ECOSCIENCE CORPORATION
/s/ Donald T. Aiello By: /s/ Harold A. Joannidi
- -------------------- --------------------------
Donald T. Aiello Harold A. Joannidi
WITNESS:
/s/ Donald T. Aiello /s/ Michael A. DeGiglio
- -------------------- --------------------------
Donald T. Aiello Michael A. DeGiglio
/s/ Donald T. Aiello /s/ Albert Vanzeyst
- -------------------- --------------------------
Donald T. Aiello Albert Vanzeyst
/s/ Donald T. Aiello /s/ J. Kevin Cobb
- -------------------- --------------------------
Donald T. Aiello J. Kevin Cobb
/s/ Donald T. Aiello /s/ Thomas Montanti
- -------------------- --------------------------
Donald T. Aiello Thomas Montanti
87
<PAGE>
Schedule I
Michael A. DeGiglio
Thomas Montanti
Albert Vanzeyst
J. Kevin Cobb
88
<PAGE>
ECOSCIENCE CORPORATION
EXHIBIT 10.59
- --------------------------------------------------------------------------------
[GRAPHIC OMITTED] Silicon Valley Bank
Amendment to Loan Documents
Borrower: EcoScience Corporation
EcoScience Product Systems Corp.
Agro Dynamics, Inc.
Agro Dynamics Canada Inc.
Date: September 25, 1998
THIS AMENDMENT TO LOAN DOCUMENTS is entered into between SILICON VALLEY
BANK ("Silicon") and the borrower named above ("Borrower").
The Parties agree to amend the Loan and Security Agreement between them
dated April 28, 1997, as amended from time to time (as amended, the "Loan
Agreement"), as follows, effective as of the date hereof. (Capitalized terms
used but not defined in this Amendment, shall have the meanings set forth in the
Loan Agreement.)
1. Modification of Section 6.1. Section 6.1 of the Loan Agreement is hereby
amended in its entirety to read as follows, which amendment shall be deemed
effective as of the date hereof:
6.1 Maturity Date. This Agreement shall continue in effect until the
maturity date set forth on the Schedule (the "Maturity Date"),
which as of the date hereof is December 28, 1998; provided that
the Maturity Date shall automatically be extended, and this
Agreement shall automatically and continuously renew, for
successive additional terms of one year each, unless one party
gives written notice to the other, not less than thirty days
prior to the Maturity Date, that such party elects to terminate
this Agreement effective on the Maturity Date.
2. Modified Maturity Date. Section 4 of the Schedule to Loan and Security
Agreement is hereby amended to read as follows:
89
<PAGE>
"4. MATURITY DATE
(Section 6.1): December 28, 1998, subject to automatic renewal as provided
in Section 6.1 above, and early termination as provided in
Section 6.2 above."
3. Fee. Borrower shall pay to Silicon a fee of $4,500 in connection with
this Amendment, which is in addition to all other amounts payable under the Loan
Agreement and which is not refundable.
4. Representations True. Borrower represents and warrants to Silicon that
all representations and warranties set forth in the Loan Agreement, as amended
hereby, are true and correct.
5. General Provisions. This Amendment, the Loan Agreement, any prior
written amendments to the Loan Agreement signed by Silicon and Borrower, and the
other written documents and agreements between Silicon and Borrower set forth in
full all of the representations and agreements of the parties with respect to
the subject matter hereof and supersede all prior discussions, representations,
agreements and understandings between the parties with respect to the subject
hereof. Except as herein expressly amended, all of the terms and provisions of
the Loan Agreement, and all other documents and agreements between Silicon and
Borrower shall continue in full force and effect and the same are hereby
ratified and confirmed.
Borrower: Silicon:
EcoScience Corporation SILICON VALLEY BANK
By /s/ Michael A. DeGiglio By /s/ Patrick J. O'Donnell
----------------------------- ------------------------
President or Vice President Title Vice President
---------------------
By /s/ Harold A. Joannidi
----------------------------
Secretary or Ass't Secretary
Borrower:
Eco Science Produce Systems Corp.
By /s/ Michael A. DeGiglio
----------------------------
President or Vice President
By /s/ Harold A. Joannidi
----------------------------
Secretary or Ass't Secretary
90
<PAGE>
Borrower:
Agro Dynamics, Inc.
By /s/ Michael A. DeGiglio
----------------------------
President or Vice President
By /s/ Harold A. Joannidi
----------------------------
Secretary or Ass't Secretary
Borrower:
Agro Dynamics Canada Inc.
By /s/ Michael A. DeGiglio
----------------------------
President or Vice President
By /s/ Harold A. Joannidi
----------------------------
Secretary or Ass't Secretary
91
<PAGE>
CONSENT
The undersigned acknowledges that his consent to the foregoing Agreement is
not required, but the undersigned nevertheless does hereby consent to the
foregoing Agreement and to the documents and agreements referred to therein and
to all future modifications and amendments hereto, and any termination hereof,
and to any and all other present and future documents and agreements between or
among the foregoing parties. Nothing herein shall in any way limit any of the
terms or provisions of the Continuing Guaranty of the undersigned, all of which
are hereby ratified and affirmed.
EcoScience Corporation EcoScience Product Systems Corp.
By /s/ Michael A. DeGiglio By /s/ Michael A. DeGiglio
----------------------------- ----------------------------
President or Vice President President or Vice President
By /s/ Harold A. Joannidi By /s/ Michael A. DeGiglio
----------------------------- ----------------------------
Secretary or Ass't Secretary Secretary or Ass't Secretary
Agro Dynamics, Inc. Agro Dynamics Canada Inc.
By /s/ Michael A. DeGiglio By /s/ Michael A. DeGiglio
----------------------------- ----------------------------
President or Vice President President or Vice President
By /s/ Harold A. Joannidi By /s/ Harold A. Joannidi
----------------------------- ---------------------------
Secretary or Ass't Secretary Secretary or Ass't Secretary
92
ECOSCIENCE CORPORATION
EXHIBIT 21
- --------------------------------------------------------------------------------
<TABLE>
<CAPTION>
SUBSIDIARIES OF THE REGISTRANT
State / Provident of
Legal Name of Subsidiary Subsidiary of Incorporation
- -------------------------------- ---------------------- ---------------------
<S> <C> <C>
Agro Dynamics, Inc. EcoScience Corporation Delaware
Agro Dynamics Canada Inc. Agro Dynamics, Inc. Ontario, Canada
EcoScience Produce Systems Corp. EcoScience Corporation Delaware
Agro Acquisition Corporation EcoScience Corporation Delaware
</TABLE>
Agro Power Development, Inc., a Delaware Corporation ("APD"), and a subsidiary
of EcoScience Corporation. APD develops, constructs and operates highly
intensive agricultural greenhouse projects, and markets and sells the vegetable
production of these facilities, as well as fresh vegetables produced by other
greenhouse growers, primarily to retail supermarkets and dedicated wholesale
distribution companies. APD has 14 subsidiaries operating in the United States
and one subsidiary operating in Morocco, all of which are operating in the same
line of business.
93
ECOSCIENCE CORPORATION
EXHIBIT 23
- --------------------------------------------------------------------------------
ARTHUR ANDERSEN LLP
CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
As independent public accountants, we hereby consent to the incorporation of our
report dated August 26, 1998 included in this Form 10-K into EcoScience
Corporation's previously filed Registration Statements File Numbers 33-55206,
33-83184, 33-31144 and 33-325341.
ARTHUR ANDERSEN LLP
Roseland, New Jersey
October 12, 1998
94
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from the Company's
Consolidated Balance Sheet as of June 30, 1998 and Consolidated Statement of
Operations for the Year Ended June 30, 1998 and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> JUN-30-1998
<PERIOD-END> JUN-30-1998
<CASH> 358
<SECURITIES> 533
<RECEIVABLES> 2,396
<ALLOWANCES> 292
<INVENTORY> 2,326
<CURRENT-ASSETS> 7,112
<PP&E> 1,443
<DEPRECIATION> 548
<TOTAL-ASSETS> 9,626
<CURRENT-LIABILITIES> 6,333
<BONDS> 7
0
0
<COMMON> 105
<OTHER-SE> 3,031
<TOTAL-LIABILITY-AND-EQUITY> 9,626
<SALES> 22,317
<TOTAL-REVENUES> 22,317
<CGS> 17,583
<TOTAL-COSTS> 17,583
<OTHER-EXPENSES> 5,671
<LOSS-PROVISION> 142
<INTEREST-EXPENSE> 148
<INCOME-PRETAX> (967)
<INCOME-TAX> 0
<INCOME-CONTINUING> (967)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (967)
<EPS-PRIMARY> (0.09)
<EPS-DILUTED> (0.09)
</TABLE>
